HIV/AIDS

More than 33 million people around the world are currently living with human immunodeficiency virus (HIV). While huge progress has been made in increasing access to HIV treatment in the past decade and new HIV infections have substantially declined in some regions, the pandemic continues to outpace efforts to control it. The number of newly infected people each year outnumbers those who gain access to treatment by two to one.

Defeating HIV will require a comprehensive response, and effective programs must be scaled up to treat people already infected and prevent new infections. New tools are also needed to defeat the pandemic, and investment in research and development for new products remains essential. UCSF researchers address issues across the range of HIV/AIDS studies.

Explore Related Topics

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Active Projects: 12

Project Investigator
All Topics Start date End date
UCSF Research in Implementation Sciences for Equity (RISE 2) Kirsten Bibbins-Domingo, MD, PhD HIV/AIDS, Implementation and Behavioral Science, Residencies, Fellowships, and Postdoctoral Training
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men Carol Camlin, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Human-centered Design and Communities of Practice to Improve Delivery of Home-based Tuberculosis Contact Investigation in Uganda Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Engagement in Care
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse, Residencies, Fellowships, and Postdoctoral Training
Biomarkers for Alcohol/HIV Research (BAHR) Study Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse, Treatment Adherence
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Targeted HIV/TB Strategic Information Technical Assistance for President's Emergency Plan for AIDS Relief (PEPFAR) and Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Countries George Rutherford, MD HIV/AIDS, Tuberculosis, Policy and Standards of Care, Epidemiology and Surveillance, Training and Capacity Building, Training International Scholars and Clinicians
Reducing Intersectional Stigma among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP Jae Sevelius, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
SF Bay Area MACS/WIHS Combined Cohort Study Phyllis Tien, MD HIV/AIDS, Women's Health
Cook County Clinical Research Site of the MACS/WIHS Combined Cohort Study Nancy Hessol, MSPH HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease Sulggi Lee, MD HIV/AIDS, Immunology, Genetics, Aging
Implementing a risk score to facilitate enhanced adherence support for pregnant and postpartum women at risk of viremia HIV/AIDS, Labor and Delivery

Active Projects: 1299

Project Investigator
All Topics Start date End date
Relationship Factors and Engagement in HIV Care in Malawi: A Dyadic Investigation HIV/AIDS, Engagement in Care
HIV testing and HIV surveillance HIV/AIDS, Epidemiology and Surveillance
Blood Donation and HIV Prevention in China Vincanne Adams, PhD HIV/AIDS
Mentorship for Dissertation: Resistant to Treatment: Medicine, Molecules, and the Global Politics of Drug-Resistant HIV Vincanne Adams, PhD HIV/AIDS
Recombinant Picornaviruses as AIDS Vaccines Raul Andino-Pavlovsky, PhD HIV/AIDS
Vaccine to Prevent HIV Infection in Pregnancy and Newborns Raul Andino-Pavlovsky, PhD HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Optimizing ACT use for African children in the setting of HIV and malnutrition Francesca Aweeka, PharmD HIV/AIDS, Malaria, Malnutrition, Micronutrients, Food Insecurity
Antimalarial Pharmacology in HIV Coinfected Children and Pregnant Women in Uganda Francesca Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Malaria, Women's Health, Pediatrics, Adolescent Health
International Maternal Pediatrics Adolescent AIDS Clinic (IMPAACT) Francesca Aweeka, PharmD HIV/AIDS, Malaria, Women's Health, Pediatrics
AIDS Clinical Trials Group Network Francesca Aweeka, PharmD HIV/AIDS
Pharmacokinetic analysis of dihydroartemisinin-piperaquine alongside the START-IPT Study Francesca Aweeka, PharmD HIV/AIDS, Malaria, Pediatrics
Testing Sponsor's Antiretroviral Enzyme Immunoassay Method Francesca Aweeka, PharmD HIV/AIDS
DDI study between HIV drugs (Efavirenz) and Coartem Francesca Aweeka, PharmD HIV/AIDS
Adult AIDS Clinical Trials Group (AACTG): Pharmacology Support Laboratory Francesca Aweeka, PharmD HIV/AIDS
ACTG: AIDS Clinical Trials Group; MASTER SUBCONTRACT -- U01AI068636 Francesca Aweeka, PharmD HIV/AIDS
2.1 Project Title ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD Infectious Disease, HIV/AIDS, Tuberculosis
Pediatric AIDS Clinical Trial Group (PACTG) Pharmacology Support Laboratories Francesca Aweeka, PharmD HIV/AIDS
IMPAACT: International Maternal Pediatrics Adolescent AIDS Clinic Francesca Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
ACTG: AIDS Clinical Trials Group Francesca Aweeka, PharmD HIV/AIDS, Opportunistic Infection
T001: Adult AIDS Clinical Trials Group (AACTG): Pharmacology Laboratory Francesca Aweeka, PharmD HIV/AIDS
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award Francesca Aweeka, PharmD HIV/AIDS, Pediatrics
LOC-IMPAACT Leadership Group Francesca Aweeka, PharmD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health, Systematic Reviews and Guideline Development
T003: International Maternal Pediatric Adolescent AIDS Clinical Trials Group IMPAACT Francesca Aweeka, PharmD HIV/AIDS, Women's Health, Pediatrics
Regulatory Circuits That Link Cell Fate and Virulence in Histoplasma Capsulatum Opportunistic Infection
Adolescent Medicine Trials Network for HIV/AIDS HIV/AIDS, Adolescent Health
Technical and Logistical Support for the Office of AIDS Research HIV/AIDS
HIV/STD Prevention Among Angolan Military HIV/AIDS, Risk Reduction and Prevention, Patient and Peer Education
Leadership Group for the Adolescent Medicine Trials Network HIV/AIDS, Adolescent Health
An Innovative HIV Prevention Curriculum for Medical Students of the University of Puerto Rico Medical School: Implementation and Evaluation Phase HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
CareConekta: Mobile health for a mobile population Carol Camlin, PhD HIV/AIDS, Adolescent Health, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Identifying Opportunities for HIV Prevention among Female Migrants in Kenya Carol Camlin, PhD HIV/AIDS, Women's Health, Immigration and Migration, Risk Reduction and Prevention
Understanding mobility and sexual mixing in SEARCH communities Carol Camlin, PhD HIV/AIDS, Epidemiology and Surveillance, Risk Reduction and Prevention, Patient and Peer Education
Immunodiagnosis of Active Tuberculosis in HIV-Infected Patients Adithya Cattamanchi, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
Multidrug-Resistant CA-MRSA Infections Among HIV+ Persons: CA AIDS Grant ID07-REI-129 Henry Chambers, MD Infectious Disease, Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Epidemiology and Surveillance
A Clinical Trial for Uncomplicated Skin Infections in Areas of Epidemic Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) Henry Chambers, MD Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS, Risk Reduction and Prevention
Phase III Study: Safety & Efficacy of Daptomycin Compared to Conventional Therapy in the Treatment of Subjects w/ infective endocarditis or bacteremia due to Staphylococcus aureus Henry Chambers, MD Opportunistic Infection
Epidemiologic Analysis of Data from Project Aware to Determine the Impact of Different HIV Testing Strategies on Risk Behaviors and STD Rates among HIV-Uninfected MSM Henry Chambers, MD HIV/AIDS
Prevention Umbrella for MSM in the Americas Henry Chambers, MD HIV/AIDS
Rifabutin Based Therapy for Eradication of Staph Carriage in HIV-Infected Individuals with Prior Skin Structure Infections Henry Chambers, MD HIV/AIDS, Opportunistic Infection
Innovative incentive strategies for sustainable HIV testing and linkage to care Gabriel Chamie, MD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Sustainable approaches to care delivery in Uganda Gabriel Chamie, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diet, Exercise, and Obesity, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Leveraging social and sexual networks to reach young men with HIV testing and linkage services Gabriel Chamie, MD HIV/AIDS, Health Economics and Effectiveness, Engagement in Care, Treatment Adherence
Molecular Epidemiology and Geospatial Analysis of Tuberculosis Transmission in Uganda Gabriel Chamie, MD HIV/AIDS, Tuberculosis, Epidemiology and Surveillance
Structural Alcohol/HIV RIsk Intervention in Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS
Enhancing Care Engagement and Re-engagement Edwin Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Family-Based HIV Voluntary Testing and Counseling in Patients at Risk for Tuberculosis Edwin Charlebois, PhD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science
Structural Alcohol Intervention to Reduce HIV Risk Behavior among Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS
Novel Evaluation Methods for Multi-Level/Combination HIV Prevention Interventions Edwin Charlebois, PhD HIV/AIDS
Getting to Zero: Advancing Retention and Re-Engagement in HIV Care Demonstration Project Edwin Charlebois, PhD HIV/AIDS, Engagement in Care, Treatment Adherence
Structural Alcohol/HIV Risk Intervention in Gay Bar Patrons Edwin Charlebois, PhD HIV/AIDS, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - Seke North Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
University of Zimbabwe-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Health Systems Strengthening, Training and Capacity Building
HPTN 081 Protocol Funding - Development Costs Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Risk Reduction and Prevention
IMPAACT Yr 08 P1077 CTU MOU #2 - St. Mary's Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
HPTN 082 - Protocol Implementation Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning, Pediatrics, Newborn and Infant Health
UZ-UCSF CTU JHU IMPAACT PF: Task Order 3 Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health
HVTN 120 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS
UZ-UCSF CTU Parirenyatwa Clinical Research Site HPTN 052 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Family Planning
HVTN 703/HPTN 081 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development
St Marys - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF CTU Spilhaus Clinical Research Site HPTN 076 2nd Protocol Funding Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Drug and Diagnostics Development, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
HPTN 084 Qualitative Substudy Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Pharmacology and Drug Treatment
Seke North - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Infectious Disease, HIV/AIDS, Pediatrics, Newborn and Infant Health, Risk Reduction and Prevention
Parirenyatwa - International Maternal Pediatric Adolescent AIDS Clinical Trials Group UZ UCSF CTU Zvavahera Chirenje, MD, FRCOG HIV/AIDS, Drug and Diagnostics Development, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health, Risk Reduction and Prevention
UZ-UCSF Clinical Trials Unit Zvavahera Chirenje, MD, FRCOG Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
HVTN 107 Protocol Funding (PF) Zvavahera Chirenje, MD, FRCOG HIV/AIDS
The Bixby Center for Global Reproductive Health - Annual Research Day Conference Zvavahera Chirenje, MD, FRCOG HIV/AIDS
HPTN 084 Development Funding Zvavahera Chirenje, MD, FRCOG HIV/AIDS
Social/Sexual Networks & HIV Risk: Men of Color Kyung-Hee Choi, MPH, PhD HIV/AIDS
Influence of Stigma and Discrimination on HIV Risk among Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Risk Reduction and Prevention
Developing a Network-based HIV Prevention Intervention for MSM in China [I] Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing an HIV Prevention Intervention for HIV-Positive Men in China Kyung-Hee Choi, MPH, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Integrating HIV/STI Prevention/Treatment in China Kyung-Hee Choi, MPH, PhD HIV/AIDS
An HIV Prevalence and Risk Behavior Survey of Male Sex Workers in Shanghai, China Kyung-Hee Choi, MPH, PhD HIV/AIDS
Developing a Network-based HIV Prevention Intervention for MSM in China [II] Kyung-Hee Choi, MPH, PhD HIV/AIDS
The Medical Consequences of Different Types of Heroin Daniel Ciccarone, MD, MPH Infectious Disease, HIV/AIDS, Substance Abuse
HepC/HIV website Susan Coffey, MD HIV/AIDS, Infectious Disease
VA HIV-HEP C Website Maintenance Services Susan Coffey, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education
National Resource Center for HIV/AIDS Prevention among Adolescents (APNRC) Susan Coffey, MD HIV/AIDS
HIV-HEP C Website Maintenance Services Susan Coffey, MD Infectious Disease, HIV/AIDS, Patient and Peer Education
Women, Children, and HIV Website Susan Coffey, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Training and Capacity Building
HIV Clinical Fellowship 2018 (Fellow May Baca) Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
AIDS Education and Training Center (AETC) National Resource Center / Website Susan Coffey, MD HIV/AIDS, Opportunistic Infection, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
HIVMA Clinical Fellowship Program (Baca) Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
AETC National Resource Center / AIDS Education and Training Website Susan Coffey, MD HIV/AIDS, Training and Capacity Building
Adolescent Modules - AETC Web Site Susan Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Adolescent Modules - AETC Web Site (Cont.) Susan Coffey, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
VA HIV Website Susan Coffey, MD HIV/AIDS
Women, Children, and HIV Website (DBS) Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
Women, Children, and HIV Website Susan Coffey, MD HIV/AIDS, Women's Health, Patient and Peer Education
UMDNJ / WHO Dept. of HIV/AIDS "Development of an Annotated Inventory of PMTCT Tools and Guidelines" Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
UMDNJ / "Tanzania PMTCT Training Package" Susan Coffey, MD HIV/AIDS, Women's Health, Pediatrics, Training and Capacity Building
AETC National Coordinating Resource Center, Center for HIV Information UCSF S. Coffey Susan Coffey, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Infectious Disease, HIV/AIDS, Tuberculosis, Malaria, Surgery and Anesthesia, Cancer/Oncology, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Pediatrics, Policy and Standards of Care, Epidemiology and Surveillance
Integrating Family Planning Services into HIV Care and Treatment in Nyanza Province, Kenya - Phase II Craig Cohen, MD, MPH HIV/AIDS
Phase 2 placebo-controlled randomized trial of LACTIN-V (Lactobacillus crispatus CTV-05) among women at high risk of HIV acquisition in Durban, South Africa Craig Cohen, MD, MPH HIV/AIDS, Sexually Transmitted Infections (STIs), Women's Health
(PrEP) Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV1 Acquisition within HIV1 Discordant Couples Craig Cohen, MD, MPH HIV/AIDS
East Africa IEDEA Regional Consortium Craig Cohen, MD, MPH HIV/AIDS, Tuberculosis, Cancer/Oncology, Epidemiology and Surveillance
FACES Patient Care fund for research at Kenya Craig Cohen, MD, MPH HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology, Diet, Exercise, and Obesity, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians
HIV/HSV Study Completion Craig Cohen, MD, MPH HIV/AIDS
Integration of Family Planning into HIV Care and Treatment in Nyanza Province, Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Implementation and expansion of high quality, sustainable and comprehensive HIV prevention, care, and treatment to achieve 90-90-90 goals in Western Kenya Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening, Training International Scholars and Clinicians
Supporting the Implementation and Expansion of High Quality HIV Prevention, Care and Treatment Activities at Facility and Community Level in Kenya under PEPFAR Craig Cohen, MD, MPH HIV/AIDS, Implementation and Behavioral Science
Satellite Symposium at Microbicides 2010 on Bacterial Therapeutics Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Development of a Live Topical Microbicide for Women Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Risk Reduction and Prevention
Consequences of an Intervention to Promote the Pasteurization of Breastmilk to Reduce the Transmission of HIV from Mothers to Their Breastfed Infants Craig Cohen, MD, MPH HIV/AIDS
HIV Shedding from the Female Genital Tract Craig Cohen, MD, MPH HIV/AIDS, Women's Health
Integrating Family Planning into HIV Care and Treatment Craig Cohen, MD, MPH HIV/AIDS
Pilot Agricultural Intervention for Food Security and HIV Outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS
HIV Treatment for Research Subjects or By Researchers in Kenya Craig Cohen, MD, MPH HIV/AIDS
Phase III Randomized , Placebo-Controlled Trial of HSV-2 Suppression to Prevent HIV Transmission Among HIV Discordant Couples HSV-2/HIV Transmission Study Craig Cohen, MD, MPH HIV/AIDS
Stakeholder Meeting on the Integration of Reproductive Health and HIV/AIDS Craig Cohen, MD, MPH HIV/AIDS, Women's Health
Process Evaluation and Toolkit Development in Support of Family Planning Integration into HIV Care & Treatment in Kenya Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Family Planning, Newborn and Infant Health, Adolescent Health, Engagement in Care, Health Systems Strengthening
Impact of ART on Sexual Behaviors in Kisumu, Kenya Craig Cohen, MD, MPH HIV/AIDS
Accelerating Children's HIV/AIDS Treatment (ACT) initiative Craig Cohen, MD, MPH HIV/AIDS, Pediatrics, Access or Barriers to Care, Health Systems Strengthening, Training and Capacity Building
STAR STI CTG Craig Cohen, MD, MPH HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Newborn and Infant Health
University of California Global Health Institute Program for Fellows and Scholars Craig Cohen, MD, MPH Sexually Transmitted Infections (STIs), Zoonosis, Emerging Disease, and Drug Resistance, Neglected Tropical Diseases (NTDs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Malaria, Noncommunicable and/or Chronic Disease, Surgery and Anesthesia, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Diet, Exercise, and Obesity, Malnutrition, Micronutrients, Food Insecurity, Eye Disease and Blindness, Oral Health, Drug and Diagnostics Development, Immunology, Genetics, Pharmacology and Drug Treatment, Neurology and Mental Health, Dementia and Cognitive Impairment, Trauma and PTSD, Women's Health, Aging, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Adolescent Health, Health Economics and Effectiveness, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination, Smoking and Tobacco, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Triangulation, Global Strategic Information, Implementation and Behavioral Science, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Agricultural intervention for food security and HIV health outcomes in Kenya Craig Cohen, MD, MPH HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Health Economics and Effectiveness
Travel Scholarships for Integration of Reproductive Health and HIV/AIDS Services Conference Craig Cohen, MD, MPH HIV/AIDS
Secretion of Virulence Factors by Mycobacterium tuberculosis Infectious Disease, HIV/AIDS, Tuberculosis, Genetics
Couples-Based HIV Prevention in South Africa Lynae Darbes, PhD HIV/AIDS
HIV prevention for male couples in Africa Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Risk Reduction and Prevention
Couples in Context: A Random Control Trial (RCT) of a Couples-Based HIV Prevention Lynae Darbes, PhD HIV/AIDS, Risk Reduction and Prevention
Implementing Partner: Understanding the HIV prevention needs of men who have sex with men (MSM) and their partners in Southern Africa: KwaZulu-Natal, South Africa and Namibia Lynae Darbes, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Patient and Peer Education
A Home-Based Couples Intervention to Enhance Prevention of Mother-to-Child-Transmission (PMTCT) and Family Health in Kenya Lynae Darbes, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence
New Challenges in HIV Prevention for Gay Male Couples Lynae Darbes, PhD HIV/AIDS
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-Infected Ugandans HIV/AIDS
Oral Wash for Nucleic Acid Diagnosis and Prognosis of TB in HIV-infected Ugandans HIV/AIDS, Tuberculosis, Drug and Diagnostics Development
UCB-UCSF-MU Research Training on Tuberculosis (TB) and Other Pulmonary Complications of HIV HIV/AIDS, Opportunistic Infection, Tuberculosis, Chronic Respiratory Disease, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Combination HIV Prevention for the General Population of Adults and Youth, including Persons Living with HIV in Mozambique Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS, Implementation and Behavioral Science
Prevention for HIV-Positive Persons: An Intervention for HIV Care Providers Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Impact of a Computer-Assisted SBIRT Program in an HIV Care Setting Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
HIV prevention in Mozambique Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS, Implementation and Behavioral Science
Prevention with Positives Carol Dawson-Rose, RN, PhD, FAAN HIV/AIDS
Innate Effector Function and HIV-1 Control Steven Deeks, MD HIV/AIDS, Immunology
International Network for Strategic Initiatives in Global HIV Trials/ ICR INSIGHT Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
HIV Persistence after Successful CCR5-Depleted Stem Cell Transplantation Steven Deeks, MD HIV/AIDS
GS-US-382-3961: A Phase 1b, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of GS-9620 in Antiretroviral Treated HIV-1 Infected Controllers Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Impact of interferon-alpha inhibition on immune function and viral persistence in HIV disease Steven Deeks, MD HIV/AIDS, Immunology
Deeks Order CNICS: June 2014-Aug 2016 Steven Deeks, MD HIV/AIDS
Therapeutic vaccination and PD-1 blockade in treated HIV disease Steven Deeks, MD HIV/AIDS
HIV Specific T-Cell Responses in Rectal Mucosa Steven Deeks, MD HIV/AIDS
Treating HIV-infected Elite Controllers as a Model of HIV Remission Steven Deeks, MD HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
AIDS Clinical Trials Network (ACTG)-Deeks (Co-Vice Chair) A5296 Steven Deeks, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Pharmacology and Drug Treatment
Elite Controllers Steven Deeks, MD HIV/AIDS, Immunology, Genetics
Measuring the Latent reservoir for HIV Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Impact of HIV-Associated Inflammation on Disease Steven Deeks, MD HIV/AIDS
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD HIV/AIDS
Enhancing Control of HIV by Inhibiting TRAIL Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
Atripla Adherence and Resistance Relationships [II] Steven Deeks, MD HIV/AIDS, Treatment Adherence
Identifying and Targeting HIV Persistence in T Cell Subsets during ART Steven Deeks, MD HIV/AIDS
Epigenetic Regulation of HIV Latency Steven Deeks, MD HIV/AIDS
Characterization of the HIV-1 Latent Reservoir in CCR5-Delta 32 Heterozygotes Steven Deeks, MD HIV/AIDS
Interruption of Enfuvirtide in Patients Experiencing an Incomplete Virologic Response to Enfuvirtide-Based Combination Antiretroviral Regimen Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Controllers: A Potential Model for HIV Eradication Steven Deeks, MD HIV/AIDS, Immunology
Validation of Existing Ultra-Sensitive Assays for Quantifying HIV Persistence Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
DARE: Delaney AIDS Research Enterprise to Find a Cure Steven Deeks, MD HIV/AIDS
Preventing the Establishment of Enfuvirtide-Resistance in the Latent Reservoir Steven Deeks, MD HIV/AIDS
Master Agreement: International Network for Strategic Initiatives in Global HIV Trials/ICR INSIGHT Steven Deeks, MD HIV/AIDS
Immediate Salvage Therapy w/ Combination ART plus T-20 vs. A 16 Week Structured Treatment Interruption Followed by Combination Therapy plus T-20 Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Combination immune checkpoint blocker inhibition to eliminate HIV latency Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Long Term Follow-Up of Patients Enrolled in Clinical Trials (#A-9602, A-9604, A-9801) Using Retroviral Gene Based Therapies / AIDS related research Steven Deeks, MD HIV/AIDS
UCSF/Ragon Collaboration on HIV "Elite" Controllers Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development, Immunology, Genetics
Raltegravir Intensification in Antiretroviral-Treated Patients Exhibiting a Suboptimal CD4+T Cell Response Steven Deeks, MD HIV/AIDS, Immunology
The Impact of Early Antiretroviral Therapy on HIV Persistence and Inflammation Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
San Francisco National Clinical Trial Center, ESPIRIT Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
T Regulatory Cells and T Cell Activation in HIV Disease Steven Deeks, MD HIV/AIDS, Immunology
Delaney AIDS Research Enterprise to Cure HIV Steven Deeks, MD HIV/AIDS, Drug and Diagnostics Development
Master Agreement: R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS Steven Deeks, MD HIV/AIDS
Atripla Adherence and Resistance Relationships [I] Steven Deeks, MD HIV/AIDS, Treatment Adherence
Short-Term Disulfiram Administration to Reverse Latent HIV Infection Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
Gender-specific Differences Affecting Reactivation of Latent HIV in Treated Patients Steven Deeks, MD HIV/AIDS, Immunology, Women's Health
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Steven Deeks, MD HIV/AIDS
Effects of CCR5 - delta-32 Heterozygosity on the HIV-1 Reservoir Steven Deeks, MD HIV/AIDS, Immunology, Genetics
Treatment Intensification for Drug-Resistant HIV Steven Deeks, MD HIV/AIDS
Impact of Sex-Based Differences on HIV Reservoir Size and Immune Activation Steven Deeks, MD HIV/AIDS, Women's Health
Viral control mechanisms of HIV-specific T cells in HIV-infected lymph node Steven Deeks, MD HIV/AIDS
Enfuvirtide Treatment Intensification in Patients with Multi-Drug Resistant HIV Steven Deeks, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Entry Inhibitors: A New Therapeutic Option Steven Deeks, MD HIV/AIDS, Immunology
Enfuvirtide Intensification for Multi-Drug Resistant HIV Steven Deeks, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
Programming Long Term Durable HIV-1 Specific T cell Responses Steven Deeks, MD HIV/AIDS, Immunology
Disulfiram to Accelerate Decay in HIV Reservoirs in ART Treated Patients Steven Deeks, MD HIV/AIDS
Characterizing the Role of Immune Activation in HIV Persistence Steven Deeks, MD HIV/AIDS, Immunology
The Microbiome, Virome and Host Response in Ventilator Associated Pneumonia Joseph Derisi, PhD Infectious Disease, Opportunistic Infection
Interactions Between HIV and Malaria in African Children Grant Dorsey, MD HIV/AIDS, Malaria
Asha HIV Health Promotion Intervention Maria Ekstrand, PhD HIV/AIDS
Reducing AIDS stigma among health professionals in South India Maria Ekstrand, PhD HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Treatment Adherence
AIDS Stigma and Gender: Health Consequences in Urban India Maria Ekstrand, PhD HIV/AIDS
AshaCare and Nutrition Program for Rural Indian Women Living with AIDS and Children Maria Ekstrand, PhD HIV/AIDS, Women's Health
Context and Correlates of Health Behaviors in South India Maria Ekstrand, PhD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Substance Abuse
Enhancing HIV Treatment Adherence in South India: The Chetana study Maria Ekstrand, PhD HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
Examining ART Adherence Issues in Bangalore, India Maria Ekstrand, PhD HIV/AIDS, Treatment Adherence
AshaCare & Nutrition Program for Rural Indian Women Living with AIDS and Children Maria Ekstrand, PhD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Women's Health, Pediatrics
Examining ART Adherence Issues in Bangalore, India Maria Ekstrand, PhD HIV/AIDS
Homeless Female Offenders Returning to the Community: Improving Hopeful Futures Maria Ekstrand, PhD HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening
Tel-Me-Box: Validating and testing a novel, low-cost, real-time monitoring device with hair level analysis among adherence-challenged patients Maria Ekstrand, PhD HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence
Reducing AIDS stigma among health professionals in South India Maria Ekstrand, PhD HIV/AIDS
Enhancing HIV treatment adherence in South India: The Chetana study Maria Ekstrand, PhD HIV/AIDS, Women's Health, Stigma and Discrimination, Implementation and Behavioral Science, Treatment Adherence
Improving Mental Health through Integration with Primary Care in Rural Karnataka Maria Ekstrand, PhD HIV/AIDS, Neurology and Mental Health, Stigma and Discrimination
Sputum M. tuberculosis DNA Kinetics during TB Treatment in Patients with HIV HIV/AIDS, Tuberculosis
Culture-Based Prediction of Adolescent HIV Risk Behavior HIV/AIDS, Adolescent Health, Risk Reduction and Prevention
The Impact of CD8 T Cells on Viral Control and Evolution in HIV-Infected Infants Margaret Feeney, MD HIV/AIDS
The Immune Response to Acute Perinatal HIV Infection Margaret Feeney, MD HIV/AIDS
Analysis of HIV-Specific Lymphocytes in Infants Using Single-Cell Microtools Margaret Feeney, MD HIV/AIDS
HIV/AIDS Clinical Care Training Program for Japanese Physicians Mitchell Feldman, MD HIV/AIDS, Training and Capacity Building
Japanese Health Professionals HIV/AIDS Training Program Mitchell Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
International Medical Program for AIDS Clinical Training Mitchell Feldman, MD HIV/AIDS, Training International Scholars and Clinicians
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS
Plugging Hair ARV Levels as Adherence Biomarkers into HIV Prevention Trials Monica Gandhi, MD, MPH HIV/AIDS, Women's Health, Newborn and Infant Health, Treatment Adherence
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
AIDS Clinical Trials Group Monica Gandhi, MD, MPH HIV/AIDS
Hair Extensions;: Using Hair Levels to Interpret Adherence, Effectiveness and Pharmacokinetics with Real-World Oral PrEP, the Vaginal Ring, and Injectables Monica Gandhi, MD, MPH HIV/AIDS
Positive Health Access to Services and Treatment (PHAST) Monica Gandhi, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Assessing Antiretroviral Exposure in Diverse Populations Monica Gandhi, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
HIV Clinical Fellowship Monica Gandhi, MD, MPH HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Hair measures to assess adherence and explain outcomes in an HIV clinical trial Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Ryan White Title IV Women, Infants, Children, Youth and Affected Family Members AIDS Healthcare Monica Gandhi, MD, MPH HIV/AIDS
Point-of-care Urine Monitoring of Adherence (PUMA): Testing a Real-Time Urine Assay of Tenofovir in PrEP Monica Gandhi, MD, MPH HIV/AIDS, Women's Health, Treatment Adherence
Intervention to reduce drug use and HIV incidence among high PrEP priority partnered YMSM Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Family Services Network - Ryan White HIV/AIDS Program Monica Gandhi, MD, MPH HIV/AIDS, Patient and Peer Education
Development of a point of care urine tenofovir immunoassay to distinguish adherence versus resistance-based HIV treatment failure Monica Gandhi, MD, MPH HIV/AIDS, Treatment Adherence
Expanded Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria Monica Gandhi, MD, MPH HIV/AIDS, Neurology and Mental Health, Dementia and Cognitive Impairment
Herpesviral Gene Expression in Kaposi's Sarcoma HIV/AIDS, Cancer/Oncology, Genetics
Adaptive Strategies for Preventing and Treating Lapses of Retention in Care (AdaPT-R) HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening
Evaluation of Haiti Quality Improvement of HIV Care HIV/AIDS, Implementation and Behavioral Science, Health Systems Strengthening
Quality Improvement Evaluation Center (Q-IEC) HIV/AIDS
R24 for the CFAR-Network for the Integrated Clinical Sciences, CNICS HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Geng's work Order fee for Service Agreement / BMS MI A1424-562 HIV/AIDS
Work Order for CNICS Admin Core 5 Years (related to NIH R24 A1067039) HIV/AIDS, Epidemiology and Surveillance
Early Mortality in HIV-Infected Patients Starting Antiretroviral Therapy in Africa HIV/AIDS, Pharmacology and Drug Treatment
R24 for the CFAR-Network for the Integrated Clinical Science, CNICS HIV/AIDS, Epidemiology and Surveillance
Geng Work Order RTI Health Solutions (Services for RTI/ViiV) HIV/AIDS
Mentoring Multidisciplinary Patient-Oriented Research in Engagement in HIV Care HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
IeDEA Consortium East Africa data center HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Evaluation of Haiti Quality Improvement of HIV Care HIV/AIDS, Implementation and Behavioral Science
Tenofovir Kidney Toxicity Study HIV/AIDS, Pharmacology and Drug Treatment
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building, UCSF Professional Education
UCSF - Ethiopia Fitun Warmline Ronald Goldschmidt, MD HIV/AIDS
Monitoring and Evaluating the State Legislative /Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-Care Settings Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
AIDS Education and Training Center, Telehealth Training Centers Program Ronald Goldschmidt, MD HIV/AIDS
Monitoring and Evaluating the State Legislative/Regulatory Framework of HIV Testing Laws to Facilitate Implementation of HIV Screening in Health-care Settings Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development
Health Marketing Services for the CDC Act Against AIDS campaigns: HIV Screening Standard Care for Primary Care Physicians (HSSC) & One Test Two Lives (OTTL) for Obstetrical Providers Ronald Goldschmidt, MD HIV/AIDS
National HIV Training and Technical Cooperative Agreements-Focus Area: HIV/AIDS Medical Homes Ronald Goldschmidt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Training and Capacity Building
National HIV/AIDS Clinicians' Consultation Center Ronald Goldschmidt, MD HIV/AIDS
AIDS Education and Training Center, National Clinician Consultation Center Ronald Goldschmidt, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
The New York Pepline Ronald Goldschmidt, MD HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Lutheran MC US-Caribbean HIV/AIDS Twinning Initiative Ronald Goldschmidt, MD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building
The New York PEPline Ronald Goldschmidt, MD HIV/AIDS, UCSF Professional Education, Patient and Peer Education
Oral Manifestations of AIDS John Greenspan, BDS, PhD HIV/AIDS
For the Sarlo Teaching Award of the UCSF AIDS Research Institute John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
HIV-Related Oral Diseases Among Women in Harare John Greenspan, BDS, PhD HIV/AIDS, Women's Health
Sarlo Award for Excellence in Teaching for the AIDS Research Institute at UCSF John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Teaching in Excellence Award for the AIDS Research Institute John Greenspan, BDS, PhD HIV/AIDS, Training and Capacity Building
Mobile technology to extend clinic-based counseling for HIV+s in Uganda Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Measurement of Alcohol Use among HIV-Positives in Uganda Judith Hahn, PhD, MD HIV/AIDS
Training in Research Program on Alcohol Use by Persons with our at Risk for HIV, Hahn K24 Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Training in Research Program on Alcohol Use by Persons-with-or-at-Risk for HIV Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
URBAN ARCH (3/5) Uganda Cohort - TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety, tolerability, and adherence, Hahn U01 Renewal Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse
Interventions to reduce alcohol use and increase adherence to TB preventive therapy among HIV/TB co-infected drinkers (DIPT 1/2) Judith Hahn, PhD, MD HIV/AIDS, Tuberculosis, Substance Abuse, Treatment Adherence
Integrating Alcohol Screening and Brief Intervention into HIV Care Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Development and Pilot Testing of a Combination Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement among Fisherfolk in Uganda Judith Hahn, PhD, MD HIV/AIDS, Engagement in Care, Substance Abuse, Risk Reduction and Prevention
HIV Voluntary Testing and Counseling (VCT) and Linkage to Care in Uganda Judith Hahn, PhD, MD HIV/AIDS
Changes in Alcohol Consumption in HIV Positives in Uganda Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Impact of Heavy Alcohol Use on Pre-ART HIV Disease -- Uganda ARCH Cohort Judith Hahn, PhD, MD HIV/AIDS, Substance Abuse
Oral Drug Treatment for Enhanced Immune Control over HIV Replication HIV/AIDS, Pharmacology and Drug Treatment
Regulatory T Cell Influence on Infant and Adult Immune Responses to HIV HIV/AIDS
Treatment to Reduce Inflammation and Improve Immune Recovery Among Older HIV Patients HIV/AIDS, Noncommunicable and/or Chronic Disease
Administration of an ACE Inhibitor to Improve Endothelial Function in Treated, HIV-infected Individuals HIV/AIDS, Cardiovascular Disease
Treating HIV-Infected Elite Controllers as a Model of HIV Remission HIV/AIDS, Immunology
Administration of an ACE-Inhibitor to Decrease the Latent Reservoir HIV/AIDS
ACE-Inhibitors to Decrease Lymphoid Fibrosis and the Size of the Latent Reservoir in Antiretroviral-Treated, HIV-infected Patients: A Randomized, Placebo-Controlled Study HIV/AIDS, Pharmacology and Drug Treatment
Treating HIV-Infected Elite Controllers as a Model of HIV Remission HIV/AIDS
Inflammatory and Clinical Consequences of Low-Level Viremia in HIV-1 Infected Patients HIV/AIDS, Immunology
Virologic and Host Factors Contributing to HIV Control in Elite Controllers HIV/AIDS
ADS-TCAD-P0206: TCAD Oral for Treatment of Influenza A Diane Havlir, MD Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
Trial of Raltegravir Plus Darunavir/Ritonavir for Treatment-Naive HIV-1-Infected Subjects (ATCG A5262) Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Therapeutic Strategies for HIV Disease Diane Havlir, MD HIV/AIDS
Supplement to ATCG A5254: Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load Diane Havlir, MD HIV/AIDS
SEARCH (Sustained East Africa Research in Community Health) Study in Kenya and Uganda/ Gates Diane Havlir, MD HIV/AIDS, Tuberculosis, Malaria, Cardiovascular Disease, Diabetes
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden Diane Havlir, MD HIV/AIDS, Tuberculosis
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa Diane Havlir, MD HIV/AIDS, Malaria, Women's Health, Pediatrics
SEARCH/AIDS Clinical Trial Research Group Diane Havlir, MD HIV/AIDS
AIDS Clinical Trials Group; Protocol Funds Diane Havlir, MD HIV/AIDS
Training in HIV Translational Research Diane Havlir, MD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
Therapeutic Strategies for HIV Disease Diane Havlir, MD HIV/AIDS
Effect of Pitavastatin on Kidney Function in HIV-infected Persons Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
Reducing Failure-to-Initiate ART: Streamlined ART Start Diane Havlir, MD HIV/AIDS, Access or Barriers to Care, Implementation and Behavioral Science, Engagement in Care
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building
Neurological AIDS Research Consortium Diane Havlir, MD HIV/AIDS
Task Order # 7: Supplement to SSS A5254 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Oral Health
AIDS Clinical Trials Group: REPRIEVE Trial (A5332 and A5333s) Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
AIDS Research and Services at SF General Hospital Diane Havlir, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Task Order # 9: Supplement to SSS A5272 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Effect of low dose methotrexate on endothelial function and inflammation in HIV - A5314 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (I) Diane Havlir, MD HIV/AIDS, Malaria
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
Training in HIV Primary Care - Uganda Clinicians Diane Havlir, MD HIV/AIDS, Training and Capacity Building
Productive and Latent HIV Infection in Gut Mucosal Reservoirs Diane Havlir, MD HIV/AIDS
Task Order A5303: Trial to Determine the Bone, Immunologic, Virologic, and Neurocognitive Effects of a Novel Maraviroc-Containing Antiretroviral Regimen in Treatment-Naive Patients Infected with R5-Tropic HIV-1 Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
TO#5 ACTG-Clinical Research Site - Community Health Promoter Position Diane Havlir, MD HIV/AIDS
Clinical Care Response Team Introduction of Antiretroviral Therapy in Elizabeth Glaser Pediatric AIDS Foundation Sites Diane Havlir, MD HIV/AIDS, Pediatrics
Training in HIV Translational Research Diane Havlir, MD HIV/AIDS, Training and Capacity Building
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START) Diane Havlir, MD HIV/AIDS
UCSF HIV/AIDS Management Training Programs Diane Havlir, MD HIV/AIDS, Training and Capacity Building
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa (PROMOTE) Diane Havlir, MD HIV/AIDS, Malaria, Pharmacology and Drug Treatment, Women's Health, Pediatrics, Newborn and Infant Health
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Uganda (II) Diane Havlir, MD HIV/AIDS
Task Order # 6: Supplement to SSS A5257 Diane Havlir, MD HIV/AIDS
AIDS Research and Services at SFGH Diane Havlir, MD HIV/AIDS
SFBay CTU Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
International AIDS Research and Prevention Diane Havlir, MD HIV/AIDS
AIDS Clinical Trials Group (ACTG) TTSG Services Diane Havlir, MD HIV/AIDS
HIV/TB in Uganda: Punctuated Antiretroviral Therapy Diane Havlir, MD HIV/AIDS, Tuberculosis
UCSF HIV Clinical Trials Unit Diane Havlir, MD HIV/AIDS
Heals Endowment Fund at the East Bay Community Foundation Diane Havlir, MD HIV/AIDS
AIDS Clinical Trial Group (ACTG) Tuberculosis TSG Services Diane Havlir, MD HIV/AIDS, Tuberculosis
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and Uninfected Pulmonary Tuberculosis Suspects Diane Havlir, MD HIV/AIDS, Tuberculosis
Sustainable East Africa Research in Community Health Diane Havlir, MD HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
Task Order Supplement to A5267 Diane Havlir, MD HIV/AIDS, Tuberculosis, Pharmacology and Drug Treatment
Sustainable East Africa Research in Community Health (SEARCH) Diane Havlir, MD HIV/AIDS, Infectious Disease, Noncommunicable and/or Chronic Disease, Health Economics and Effectiveness, Access or Barriers to Care
AIDS Clinical Trial Group Network- Protocol Funding Agreement (Core Funding) Diane Havlir, MD HIV/AIDS
Task Order A5280: A Prospective, Randomized Pilot Trial of High Dose Vitamin D and Calcium for Bone Health in HIV-Infected Individuals Initiating Highly Active Antiretroviral Therapy (HAART) Diane Havlir, MD HIV/AIDS
Clinical Studies of Interactions Between HIV and Malaria Diane Havlir, MD HIV/AIDS, Malaria
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa (III) Diane Havlir, MD HIV/AIDS, Malaria
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN) Diane Havlir, MD HIV/AIDS, Adolescent Health
ACTG, AIDS Clinical Trial Research Group Diane Havlir, MD HIV/AIDS, Opportunistic Infection
Study of Three NNNRTI-Sparing Antiretroviral Regimens for Treatment-Naive HIV-1-Infected Volunteers (ACTG A5257) Diane Havlir, MD HIV/AIDS, Pharmacology and Drug Treatment
Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG) Diane Havlir, MD HIV/AIDS
AIDS Clinical Trials Group (ACTG) Community Health Promoter Diane Havlir, MD HIV/AIDS
AIDS Clinical Trials Group: REPRIEVE Trial Ancillary Study Diane Havlir, MD HIV/AIDS, Cardiovascular Disease
Adult AIDS Clinical Trials Unit (AACTU) Diane Havlir, MD HIV/AIDS
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy of A5257 (ACTG A5260s) Diane Havlir, MD HIV/AIDS
AIDS Clinical Trial Research Group (ACTG), Studies: A5306, A5254, A5298 Diane Havlir, MD HIV/AIDS, Opportunistic Infection, Tuberculosis, Oral Health
Getting to Zero Coordinator/ SFPHF Diane Havlir, MD HIV/AIDS
Improving and Evaluating HIV Response Implementation Norman Hearst, MD, MPH HIV/AIDS, Health Economics and Effectiveness, Policy and Standards of Care
Developing an International Research Program in AIDS and Substance Abuse Norman Hearst, MD, MPH HIV/AIDS, Substance Abuse
Developing an International Research Program in AIDS and Substance Abuse [II] Norman Hearst, MD, MPH HIV/AIDS
Developing an International Research Program in AIDS and Substance Abuse [I] Norman Hearst, MD, MPH HIV/AIDS, Engagement in Care, Health Systems Strengthening
HIV epidemiology and public health Norman Hearst, MD, MPH HIV/AIDS, Epidemiology and Surveillance
Primary HIV Prevention in Pregnant and Lactating Ugandan Women Jaco Homsy, MD, MPH HIV/AIDS, Women's Health
Achieving durable retention in care for PMTCT Option B+: An intervention research Jaco Homsy, MD, MPH HIV/AIDS, Women's Health, Pediatrics, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Posting at the Makerere University and Johns Hopkins University HIV Clinical Trials Unit in Kampala, Uganda Jaco Homsy, MD, MPH HIV/AIDS
HQHIV1003203 Philip Hopewell, MD HIV/AIDS, Tuberculosis
Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) HIV/AIDS, Cardiovascular Disease, Aging
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV HIV/AIDS, Cardiovascular Disease
Effect of IL-1B inhibition on inflammation and cardiovascular risk in HIV HIV/AIDS, Immunology
Epidemiology and Pathogenesis of Pulmonary Hypertension in HIV Patients HIV/AIDS, Epidemiology and Surveillance
Effect of low dose methotrexate on endothelial function and inflammation in HIV HIV/AIDS, Cardiovascular Disease
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection HIV/AIDS, Cardiovascular Disease, Pharmacology and Drug Treatment
Protein Biomarkers for CVD Prediction in HIV-Infected and Uninfected Veterans HIV/AIDS, Cardiovascular Disease
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV HIV/AIDS
Effect of low dose methotrexate on endothelial function and inflammation in HIV HIV/AIDS, Cardiovascular Disease
HIV Viral Reservoirs and Monocyte Activation in HIV-Associated Atherosclerosis HIV/AIDS, Cardiovascular Disease
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
Patient-Oriented Research and Mentoring in HIV-associated Pulmonary Diseases Laurence Huang, MD HIV/AIDS, Tuberculosis, Noncommunicable and/or Chronic Disease
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease(l)) Laurence Huang, MD HIV/AIDS
Statins for Pulmonary and Cardiac Complications of Chronic HIV (The SPARC Trial) Laurence Huang, MD HIV/AIDS
HIV and Lung Complications in the ART Era: Focus on Obstructive Lung Disease Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
PCP OPW Specimens/Uganda Project Support Laurence Huang, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
Inflammation, Aging, Microbes, and Obstructive Lung Disease (I AM OLD) Study Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
Transcriptional alternations in bronchoalveolar lavage fluid during treatment of human tuberculosis Laurence Huang, MD HIV/AIDS, Tuberculosis
Specimens Related to the MU-UCSF Research Collaboration Laurence Huang, MD HIV/AIDS
International Randomized, Controlled Phase 3 Trial of DB289 Versus Trimethoprim-Sulfamethoxazole for Treatment of Acute Pneumocystis jiroveci Pneumnia (PCP) in Patients with HIV/AIDS Laurence Huang, MD HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study Laurence Huang, MD HIV/AIDS
HIV and Lung Complications in the HAART Era: Focus on Obstructive Lung Disease (ll) Laurence Huang, MD HIV/AIDS
International HIV-Associated Opportunistic Pneumonias (IHOP) Study Laurence Huang, MD HIV/AIDS
Pathogenesis of Emphysema/Obstruction and the Microbiome (POEM) in HIV Laurence Huang, MD HIV/AIDS, Chronic Respiratory Disease
PCP OPW Specimens Laurence Huang, MD Opportunistic Infection
Cervical Cancer Screening with a Novel Biomarker in HIV-Infected Women Megan Huchko, MD HIV/AIDS, Cancer/Oncology
Evaluating a community-driven cervical cancer prevention model in western Kenya Megan Huchko, MD HIV/AIDS, Cancer/Oncology, Women's Health
IDO-induced Tryptophan Catabolism and Mortality in Treated HIV-infected Africans Peter Hunt, MD HIV/AIDS
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa Peter Hunt, MD HIV/AIDS
Inflammation, T Cell Senescence, and Mortality in Treated HIV Infection Peter Hunt, MD HIV/AIDS
The Determinants of T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS
Determinants of Functional Immune Defects in Treated HIV Infection and Aging Peter Hunt, MD HIV/AIDS, Aging
HIV-Specific T-cell Responses in Rectal Mucosa Peter Hunt, MD HIV/AIDS
Intestinal MAIT Cells in HIV Infection Peter Hunt, MD HIV/AIDS
Immunologic Determinants of CD4+ T Cell Recovery in Treated HIV+ Africans Peter Hunt, MD HIV/AIDS
HIV Pathogenesis and Immunity in Viremic Non-Progressors Peter Hunt, MD HIV/AIDS
Innate Immune Response Genetics and T cell Activation in Treated HIV Infection Peter Hunt, MD HIV/AIDS
AIDS Clinical Trials Network (ACTG) - Transformative Science Group Vice Chair) Peter Hunt, MD Infectious Disease, HIV/AIDS, Tuberculosis
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD HIV/AIDS, Cardiovascular Disease, Chronic Respiratory Disease, Aging
Mesalamine to Reduce T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS, Drug and Diagnostics Development
AIDS Clinical Trials Network (ACTG) -- Peter Hunt Task Order Peter Hunt, MD HIV/AIDS
Cardiovascular, Pulmonary & Hematological Disease in HIV: Prevention & Treatment Peter Hunt, MD HIV/AIDS, Cancer/Oncology, Cardiovascular Disease, Aging
Impact of Cannabis on Inflammation and Viral Persistence in Treated HIV/SIV Peter Hunt, MD HIV/AIDS, Immunology
Valganciclovir to Reduce T Cell Activation in HIV Infection Peter Hunt, MD HIV/AIDS, Drug and Diagnostics Development, Immunology
AIDS Clinical Trials Network (ACTG)- Peter Hunt Task Order Peter Hunt, MD HIV/AIDS
Investigating Mechanisms of HIV Persistence in the Gut Peter Hunt, MD HIV/AIDS, Immunology
Implementation science research on ART delivery in resource limited settings Vivek Jain, MD HIV/AIDS, Implementation and Behavioral Science
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention
RAPID-VL: Optimizing HIV Viral Load Monitoring and Outcomes for High-Risk Populations Vivek Jain, MD HIV/AIDS, Drug and Diagnostics Development
Early Antiretroviral Therapy in Resource Limited Settings in Patients with High CD4+ Cell Counts Vivek Jain, MD HIV/AIDS, Pharmacology and Drug Treatment
HIV Neurocognitive Disorders: A Randomized Clinical Trial of CNS-Targeted HAART HIV/AIDS
HIV Emergence of Drug Resistance Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Pharmacology and Drug Treatment
AIDS Malignancy Consortium (AMC) Lawrence Kaplan, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
AIDS Malignancies Consortium Lawrence Kaplan, MD HIV/AIDS, Cancer/Oncology
Web-Based, Structural HIV Prevention in MSM's Networks Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Prevention for African American Down Low Men Susan Kegeles, PhD HIV/AIDS, Engagement in Care
Moving a Research-Based Intervention into Practice Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS
Community Mobilization to Improve the HIV/AIDS Continuum of Care among Black Men Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD HIV/AIDS
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Risk Reduction and Prevention, Patient and Peer Education
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Training and Capacity Building, Patient and Peer Education
Mpowerment Project Training Agreement Susan Kegeles, PhD HIV/AIDS, Training and Capacity Building, Patient and Peer Education
HIV Prevention for Transgender Individuals Susan Kegeles, PhD HIV/AIDS, Engagement in Care
Development of a Multilevel HIV Prevention for Latin American Men Susan Kegeles, PhD HIV/AIDS
NIMH Collaborative HIV/STD Prevention Trial Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science
Addressing the Continuum of Prevention and Care among High-Risk Thai Men Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention, Patient and Peer Education
Community-level HIV Prevention Intervention for Young Black Men Susan Kegeles, PhD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care
Pilot of Culturally Tailored Mpowerment for HIV Prevention Among YMSM in Beirut Susan Kegeles, PhD HIV/AIDS, Adolescent Health, Access or Barriers to Care, Risk Reduction and Prevention, Patient and Peer Education
Community Mobilization to Improve the HIV/AIDS Continuum of Care Among Black Men Susan Kegeles, PhD HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
HIV Prevention and Care for Peruvian MSM and Transgender Women Susan Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Faith-based HIV Prevention for African American MSM Susan Kegeles, PhD HIV/AIDS
HIV Prevention for African American Down Low Men Susan Kegeles, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention, Patient and Peer Education
Multilevel HIV Prevention Intervention for Young African American Men Susan Kegeles, PhD HIV/AIDS, Risk Reduction and Prevention
HIV Translation Research for Young African American MSM Susan Kegeles, PhD HIV/AIDS, Access or Barriers to Care, Engagement in Care, Risk Reduction and Prevention
Traineeships in AIDS Prevention Studies Susan Kegeles, PhD HIV/AIDS, Neurology and Mental Health, Implementation and Behavioral Science, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Alcohol's impact on immunological and virological profiles in HIV patients Mandana Khalili, MD HIV/AIDS, Immunology, Substance Abuse
HBV/HIV Co-Infection Research Network Mandana Khalili, MD Sexually Transmitted Infections (STIs), HIV/AIDS
Innate Immunity and Autophagy in Elite Controllers HIV/AIDS
Studies of Ocular Complications of AIDS (SOCA) HIV/AIDS, Eye Disease and Blindness
Integrated Biological and Behavioral Surveillance (IBBS) with Population Size Estimation using Respondent Driven Sampling (RDS) among Men who have Sex with Men (MSM) in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Triangulation
Integrated Biological Behavioral Survey with Population Size Estimation using Respondent Driven Sampling among Men who have sex with Men Timothy Lane, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Triangulation
Health Empowerment for MSM in South Africa Timothy Lane, PhD, MPH HIV/AIDS
HIV Evaluation Activities with High-Risk, Underserved Populations in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
HIV Evaluation Activities with High Risk Underserved Populations in South Africa under PEPFAR Timothy Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Peer Navigation to Improve Engagement in Care for HIV-Positive MSM in South Africa Timothy Lane, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Patient and Peer Education
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care, and Treatment Services throughout the Health System in South Africa under the President's Emergency Plan Timothy Lane, PhD, MPH HIV/AIDS, Tuberculosis, Access or Barriers to Care, Stigma and Discrimination
HIV Prevention among High-Risk Men in South Africa Timothy Lane, PhD, MPH HIV/AIDS
Identification of the CD8+ Cell Anti-HIV Factor (CAF) HIV/AIDS, Immunology
Immunologic and Virologic Features of Early HIV Infection HIV/AIDS, Risk Reduction and Prevention
UCSF AIDS Research Training Program HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Molecular Epidemiology of the Human Immunodeficiency Virus in Mexico HIV/AIDS
Subcontract from UFL Prime: HIV/FIV-Cat-Model: A model to identify vaccine epitopes HIV/AIDS
Identification of the CD8+ Cell Antiviral Factor (CAF) HIV/AIDS
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
HIV cure with CCR5 (-) human IPS hematopoietic stem cells HIV/AIDS, Risk Reduction and Prevention
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Protection from HIV Infection in Intravenous Drug Users HIV/AIDS, Substance Abuse, Risk Reduction and Prevention
JCF/Bransten Grant HIV/AIDS
Identification of the CD8 Cell Anti-HIV Factor (CAF) HIV/AIDS
HIV cure with CCR5 negative human IPS hematopoietic stem cells HIV/AIDS, Drug and Diagnostics Development, Immunology
Role of Innate Immunity in Controlling HIV Infection HIV/AIDS
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri Lippman, PhD, MPH HIV/AIDS
Toward Understanding Community Mobilization for HIV Prevention in the African Context Sheri Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Self-Conducted HIV Tests - Improving HIV Prevention in Key Populations Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Engagement in Care
Activating Treatment as Prevention through Community Mobilization in South Africa Sheri Lippman, PhD, MPH HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
Multilevel mechanisms of HIV acquisition in young South African women Sheri Lippman, PhD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Implementation and Behavioral Science
Prevention Umbrella for MSM in the Americas Sheri Lippman, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Does Shifting Gender Norms on the Community Level Lead to Increased HIV Services Uptake? Sheri Lippman, PhD, MPH HIV/AIDS, Stigma and Discrimination, Patient and Peer Education
Copy of Innovations in HIV testing to enhance care for young women and their partners Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care
Innovation Challenge CDC Sheri Lippman, PhD, MPH HIV/AIDS
Improving Health Outcomes for Women Living with HIV Sheri Lippman, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Reducing HIV Transmission in High Prevalence Districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services Sheri Lippman, PhD, MPH HIV/AIDS, Systematic Reviews and Guideline Development
GSK_201585: Phase III, randomized, multicenter, parallel-group, non inferiority, open-label study evaluating the efficacy, safety, & tolerability of switching to long-acting cabotegravir plus long acting rilpivirine from current INI,NNRTI, or PI-based ART Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Cardiovascular, Anthropometric, and Skeletal Effects of ART Initiation with FTC/TDF plus ATV/r: Metabolic Substudy (ACTG) A5260s Anne Luetkemeyer, MD HIV/AIDS
ACTG A5295: Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in HIV-Infected and HIV-Uninfected Pulmonary Tuberculosis Suspects Anne Luetkemeyer, MD HIV/AIDS, Tuberculosis
Entecavir Intensification for HIV-HBV Coinfected subjects with persistent HBV viremia Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of a Novel CCR5 Antagonist, UK427,857, for the Treatment of Antiretroviral-Experienced HIV-1-Infected Subjects Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Study of BMS-790052 plus Peg-Interferon alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected with HIV and HCV Anne Luetkemeyer, MD HIV/AIDS
DAIDS A5298 Study: A Randomized, Double-Blinded, Placebo-Controlled, Phase III Trial of the Quadrivalent HPV Vaccine to Prevent Anal Human Papillomavirus Infection in HIV-Infected Men Anne Luetkemeyer, MD HIV/AIDS, Cancer/Oncology
A phase III trial to investigate the efficacy, tolerability & safety of TMC125 as part of an ART including TMC114/RTV and an investigator-selected OBR in HIV-1 infected subjects w/ limited to no treatment options Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A Probe to Evaluate the Safety, Tolerability & Immunogenicity of the MRK Adenovirus Serotype 5 Vector Human Immunodeficiency Virus Type 1 gag Vaccine in HIV-1 Infected Anne Luetkemeyer, MD HIV/AIDS
ACTG, AIDS Clinical Trials Research Group - A5289 and A5255 Anne Luetkemeyer, MD HIV/AIDS
M14-730 (EXPEDITION-2): A Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults with Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Gilead GS-US-236-0102 Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Pfizer A4001027: Observational Phase Extension Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Metabolic Substudy of A5257, CIMT/FMD Repeat Scans (ACTG A5260s:) Anne Luetkemeyer, MD HIV/AIDS
ACTG A5294: A Prospective, Phase III Open-Label Study of Response-Guided Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in HCV/HIV Coinfected Subjects Anne Luetkemeyer, MD HIV/AIDS
GS-US-183-0130: A Phase 3, Open-Label, Multicenter Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination with Other Antiretroviral Agents in the Treatment of HIV-1 Infected Subjects Anne Luetkemeyer, MD HIV/AIDS
Tobira 652-2-202 Pre-Clinical Trial Cost Agreement Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Tibotec TMC125-C214: Early Access of TMC125 in Combination with Other Antiretrovirals in Treatment-Experienced HIV-1 Infected Subjects with Limited Treatment 0ptions Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
A Phase III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172/MK-8742 in Treatment-Naive Subjects with Chronic HCV GT1, GT4, GT5, and GT6 Infection who are on Opiate Substitution Therapy Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
A Phase 3, Open-Label Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 weeks in Subjects with Chronic HCV and HIV-1 Coinfection Anne Luetkemeyer, MD Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment
Study Evaluating the Efficacy and Safety of Pegylated Interferon Lambda-1a, in Combination with Ribavirin and Daclatasvir for Treatment of Chronic HCV Infection with Treatment Naïve Genotypes 1, 2, 3 or 4 in Subjects Coinfected with HIV-1 Anne Luetkemeyer, MD HIV/AIDS
Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267 and ABT-333 Coadministered with Ribavirin in Adults with Genotype 1 Chronic HCV and HIV Anne Luetkemeyer, MD HIV/AIDS, Pharmacology and Drug Treatment
Epidemiological studies among drug users in Iran Mohsen Malekinejad, MD, DrPH HIV/AIDS, Epidemiology and Surveillance, Substance Abuse
Immunoprotective Effects of Lopinavir/Ritonavir in HIV-Infected Patients in Sub-Saharan Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
NAAccord (CHK-UP on HIV Supplement) Jeffrey Martin, MD, MPH HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-associated Cancer Jeffrey Martin, MD, MPH HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development
East Africa IEDEA Regional Consortium Jeffrey Martin, MD, MPH HIV/AIDS
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
East Africa IEDEA Regional Consortium Jeffrey Martin, MD, MPH HIV/AIDS
Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Abbott Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Unsolicited R24 for the CFAR - Network of Integrated Clinical Sciences (CNICS) Jeffrey Martin, MD, MPH HIV/AIDS
Merck Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Gilead Drug Donation for Antiretroviral Therapy of AIDS-Related Kaposi's Sarcoma in Africa Jeffrey Martin, MD, MPH HIV/AIDS
Uganda-UCSF Research Training Program in HIV-Associated Malignancies Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology
Cohort Study of Patients Receiving Long-Term Combination Therapy [II] Jeffrey Martin, MD, MPH HIV/AIDS, Drug and Diagnostics Development
Early Stage Diagnosis of Kaposi's Sarcoma in Limited Resource Settings using KS-Detect Jeffrey Martin, MD, MPH HIV/AIDS, Cancer/Oncology, Drug and Diagnostics Development
Novel Approaches to Monitoring and Utilizing Adherence to HIV Therapy in Africa Jeffrey Martin, MD, MPH HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Jeffrey Martin, MD, MPH HIV/AIDS
Implementation science to optimize HIV prevention in East Africa PEPFAR program Jeffrey Martin, MD, MPH HIV/AIDS
The Role of PD-1 Pathway and Tissue Microenvironment in HIV-Kaposi Sarcoma and Endemic Kaposi Sarcoma Cohort in Western Kenya Toby Maurer, MD HIV/AIDS, Cancer/Oncology
Effects of Maraviroc on HIV-related Kaposi Sarcoma Toby Maurer, MD HIV/AIDS, Cancer/Oncology
HIV, Hepatitis C, and Pruritus: Data from the Women's Interagency HIV Study Toby Maurer, MD Infectious Disease, HIV/AIDS, Women's Health
Evaluation of technetium Tc 99m tilmanocept (Lymphoseek) Localization, Retention, and Distribution in Primary Cutaneous Kaposi's Sarcoma (KS) and Lymphatic Drainage from KS Lesions by SPECT and SPECT/CT Imaging Toby Maurer, MD HIV/AIDS, Cancer/Oncology, Pharmacology and Drug Treatment
Immunosenescence Profiles of Atypical Cases of Kaposi Sarcoma in Well-Controlled HIV Infection Toby Maurer, MD HIV/AIDS, Cancer/Oncology
Role of Buprenorphine in Improving Clinical Care in Opioid Addiction and HIV HIV/AIDS, Pharmacology and Drug Treatment, Substance Abuse
Interaction of Alcohol and HAART in HIV/AIDS and HIV/AIDS and HCV Coinfection HIV/AIDS
Opioids & HIV Medications: Interactions in Drug Abusers HIV/AIDS
Disulfiram Interactions With HIV Medications: Clinical Implications HIV/AIDS
Exchange of samples- Placental Biopsies Mike McCune, MD, PhD HIV/AIDS, Women's Health
Defining critical events in early HIV infection-effects of alcohol and early ART Mike McCune, MD, PhD HIV/AIDS, Immunology, Substance Abuse
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD HIV/AIDS
Early Antiretroviral Therapy and HIV Remission in Perinatal Infection Mike McCune, MD, PhD HIV/AIDS
Design of an Effective Vaccine against HIV: An Alternative Hypothesis Mike McCune, MD, PhD HIV/AIDS
Interferon-independent mechanisms of malaria restriction by helper T cells Mike McCune, MD, PhD HIV/AIDS, Malaria, Immunology
Design of an Effective Vaccine against HIV: An Alternative Hypothesis Mike McCune, MD, PhD HIV/AIDS
Novel flow cytometry-based assay for HIV-infected cells Mike McCune, MD, PhD HIV/AIDS, Risk Reduction and Prevention
Use of r-hGh to Enhance Thymopoiesis and to Facilitate Immune Restoration in Individuals Infected with HIV-1 Mike McCune, MD, PhD HIV/AIDS, Immunology
Inflammation and HIV Persistence Mike McCune, MD, PhD HIV/AIDS
The impact of TB co-infection on the reservoir of persistent HIV in vivo Mike McCune, MD, PhD HIV/AIDS, Tuberculosis, Immunology
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD HIV/AIDS
Detection and Measurement of the HIV Reservoir Mike McCune, MD, PhD HIV/AIDS
Thymic Function in Adults With HIV-1 Disease Mike McCune, MD, PhD HIV/AIDS
Timing of ART and homeostasis of the persistent HIV reservoir in the adult Mike McCune, MD, PhD HIV/AIDS, Immunology
Assessing Laboratory Correlates of Immune Protection Mike McCune, MD, PhD HIV/AIDS
HIV Proteomic Center for Host-Viral Responses Characterization Mike McCune, MD, PhD HIV/AIDS
Interruption of Maternal-Fetal Transmission of HIV Mike McCune, MD, PhD HIV/AIDS, Women's Health
HIV Effects on the Central Hematolymphoid System Mike McCune, MD, PhD HIV/AIDS
HIV Implementation Science Research Training Program John Metcalfe, MD HIV/AIDS, Training International Scholars and Clinicians
Leadership and Operations, AIDS Clinical Trial Group John Metcalfe, MD HIV/AIDS
Improving Early Identification of Drug Resistant Tuberculosis in HIV Prevalent Settings John Metcalfe, MD HIV/AIDS, Tuberculosis
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia HIV/AIDS, Dementia and Cognitive Impairment
The Development of a Tool to Identify Peripheral Neuropathy and HIV Associated Dementia HIV/AIDS, Dementia and Cognitive Impairment
Treatment of HIV-Associated Cognitive Impairment HIV/AIDS
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients HIV/AIDS
New Combination Therapies for Early Cryptococcal Infection in HIV Infected Individuals: A Randomized Controlled Trial HIV/AIDS
Development and Validation of a Diagnostic Tool for HIV Dementia HIV/AIDS, Dementia and Cognitive Impairment
Development of an Integrated Social Franchising/ Health Co-op Model to Address TB and HIV among Poor in Sub-Saharan Africa Dominic Montagu, DrPH HIV/AIDS, Tuberculosis, Health Economics and Effectiveness
Understanding the Acceptability of Pre-Exposure Prophylaxis (PrEP) to Prevent HIV among Men Who Have Sex with Men and Transgender People in California Stephen Morin, PhD HIV/AIDS, Risk Reduction and Prevention
AIDS Policy Research Center [I] Stephen Morin, PhD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Using ELI Data to Guide HIV Prevention in California Stephen Morin, PhD HIV/AIDS, Epidemiology and Surveillance
Center for AIDS Prevention Studies Stephen Morin, PhD HIV/AIDS
Center for AIDS Prevention Studies Stephen Morin, PhD HIV/AIDS
Enhanced Comprehensive HIV Prevention Planning and Implementation for Metropolitan Statistical Areas Most Affected by HIV/AIDS Stephen Morin, PhD HIV/AIDS, Engagement in Care, Risk Reduction and Prevention
Community-Based HIV VCT: Zimbabwe Stephen Morin, PhD HIV/AIDS, Risk Reduction and Prevention
Health-Related Interventions for Persons Living with HIV Stephen Morin, PhD HIV/AIDS, Systematic Reviews and Guideline Development
AIDS Policy Research Center [II] Stephen Morin, PhD HIV/AIDS, Health Economics and Effectiveness, Access or Barriers to Care, Epidemiology and Surveillance, Implementation and Behavioral Science, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
HIV Testing, Prevention and Treatment in Health Centers Survey Tool Stephen Morin, PhD HIV/AIDS, Patient and Peer Education
AIDS Policy Research Center Stephen Morin, PhD HIV/AIDS, Health Economics and Effectiveness
Building Community Partnerships: Case Studies at Three HPTN Sites Stephen Morin, PhD HIV/AIDS, Health Systems Strengthening, Training International Scholars and Clinicians
Community-based VCT: Zimbabwe Stephen Morin, PhD HIV/AIDS
Center for AIDS Prevention Studies (CAPS) Stephen Morin, PhD HIV/AIDS, Risk Reduction and Prevention
A San Francisco Street Youth Cohort: At-Risk and HIV+ Anna-Barbara Moscicki, MD HIV/AIDS, Adolescent Health, Engagement in Care, Risk Reduction and Prevention, Training and Capacity Building, Patient and Peer Education
Pediatric HIV/AIDS Cohort Study (PHACS) Anna-Barbara Moscicki, MD HIV/AIDS, Pediatrics, Adolescent Health
HPV Infections and Associated Morbidity in Children and Adolescents Perinatally Infected with HIV Anna-Barbara Moscicki, MD HIV/AIDS, Pediatrics, Epidemiology and Surveillance
A Positive Affect Intervention for Those Recently Diagnosed with HIV HIV/AIDS, Implementation and Behavioral Science
Positive Affect Regulation for HIV Prevention in People with Mood Disorders HIV/AIDS
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Domestic Hub Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
TO#2 Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine
Retrovirus Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
XV International Conference on Human Retrovirology: HTLV and Related Viruses Edward Murphy, MD, MPH HIV/AIDS, Infectious Disease, Transfusion Medicine
Research training in HIV-related transfusion medicine and hematology in South Africa Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Health Systems Strengthening, Training and Capacity Building
XI International Conference on Human Retrovirology: HTLV Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine
Master Agreement: Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - International Sites Edward Murphy, MD, MPH HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance, Training and Capacity Building
Conduct a systematic review of interventions to improve adherence and retention during TB and HIV co-treatment among people living with HIV Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis, Systematic Reviews and Guideline Development, Treatment Adherence
Sputum Transcriptomic Expression Profiling in Study 31: Express 31 Payam Nahid, MD, MPH HIV/AIDS, Tuberculosis
Minority Communities HIV Prevention Research Training Torsten Neilands, PhD HIV/AIDS, Training and Capacity Building
The Training Program for Scientists Conducting Research to Reduce HIV/AIDS Health Disparities Torsten Neilands, PhD HIV/AIDS, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
A Randomized Trial to Prevent HIV Among Gay Couples Torsten Neilands, PhD HIV/AIDS, Risk Reduction and Prevention
The Training Program for Scientists Conducting Research to Reduce HIV/AIDS Health Disparities Torsten Neilands, PhD HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Relationship Power and HIV Risk in Gay Male Couples Torsten Neilands, PhD HIV/AIDS, Implementation and Behavioral Science
NIH Study of HIV/AIDS Stigma Reduction Torsten Neilands, PhD HIV/AIDS
Migration, Tourism and the HIV-drug use Syndemic in the Dominican Republic Torsten Neilands, PhD HIV/AIDS, Immigration and Migration, Epidemiology and Surveillance, Substance Abuse
The Collaborative HIV Prevention Research in Minority Communities Program Torsten Neilands, PhD HIV/AIDS
Minority Populations Prevention Researcher Training Torsten Neilands, PhD HIV/AIDS, Risk Reduction and Prevention, Residencies, Fellowships, and Postdoctoral Training
Collaborative HIV Prevention in Minority Communities Torsten Neilands, PhD HIV/AIDS
AIDS Stigma Among Health Professionals in Puerto Rico Torsten Neilands, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Implementation and Behavioral Science
Improving HAART Adherence in HIV+ Active Drug Users HIV/AIDS
Innate NKT Cells in HIV Infection HIV/AIDS
Protective Immunity in HIV Highly Exposed but Uninfected Subjects HIV/AIDS
Human Endogenous Retroelements in HIV Immunopathogenesis HIV/AIDS
Cell Mediated Immunity in HIV-Infected Children HIV/AIDS
An Endogenous Retroelement Vaccine against HIV-1 HIV/AIDS
Immunological Targeting of APOBEC Proteins to Cure HIV Infection HIV/AIDS, Immunology
Protective immunity in HIV Highly Exposed but Uninfected Subjects HIV/AIDS
A Novel APOBEC-Based Vaccine Approach for HIV HIV/AIDS
Chemoprophylaxis and HIV-Host Interactions [II] HIV/AIDS, Immunology
T Regulatory Cells in HIV Infection HIV/AIDS
Viral Tropism and Immune Control in HIV HIV/AIDS
Innate Natural Killer T (NKT) Cells in HIV Infection HIV/AIDS
Chemoprohylaxis and HIV-Host Interactions HIV/AIDS
Eliminating the Latent Reservoir through Self-Specific Antibodies HIV/AIDS
Innate NKT Cells in HIV Infection HIV/AIDS
Enhanced HIV Prevention in the Republic of Uganda HIV/AIDS, Implementation and Behavioral Science
Chemoprophylaxis and HIV-Host Interactions [I] Kimberly Page, PhD, MPH HIV/AIDS, Risk Reduction and Prevention
Safety and Pharmacokinetics of Tenofovir and Emtricitabine in HIV Negative Thai Women Kimberly Page, PhD, MPH HIV/AIDS, Women's Health, Risk Reduction and Prevention
Chemoprophylaxis for HIV Prevention in Peruvian Men Kimberly Page, PhD, MPH HIV/AIDS
Culture and HIV Prevention in Cambodia Kimberly Page, PhD, MPH HIV/AIDS, Implementation and Behavioral Science
Amphetamine-Type Stimulant (ATS) Use HIV among Young Female Sex and Entertainment Workers in Cambodia Kimberly Page, PhD, MPH HIV/AIDS
Cambodia Integrated HIV and Drug Prevention Implementation Program Kimberly Page, PhD, MPH HIV/AIDS
Health Evaluation of the Young Man Study Kimberly Page, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Risk Reduction and Prevention
International Collaborative of Prospective Studies of HIV and Hepatitis in IDU Kimberly Page, PhD, MPH HIV/AIDS, Substance Abuse
Phase 1/2 Trial of Pharmacological HIV-1 Prevention Kimberly Page, PhD, MPH HIV/AIDS
Next Generation of HPV and Cervical Cancer Research in HIV+ Women Joel Palefsky, MD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Cancer/Oncology
Women and Infants Transmission Study - Human Papillomavirus Protocol Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology, Women's Health
HPV-Related Neoplasia among HIV-Seropositive Indian Men Who Have Sex With Men Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
Incidence of HIV among Indian Men Who Have Sex with Men Joel Palefsky, MD HIV/AIDS, Epidemiology and Surveillance
Doris Duke Charitable Foundation International Clinical Research Fellowship Program Joel Palefsky, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Oral Health, Neurology and Mental Health, Women's Health, Pediatrics, Newborn and Infant Health, Immigration and Migration, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
A Phase II Study to Evaluate the Immunogenicity and Safety of a Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Females Joel Palefsky, MD HIV/AIDS
Natural History of Anal Neoplasia in HIV-Infected Men Joel Palefsky, MD HIV/AIDS
Epidemiologic Effects of ART on HIV-related Anal Cancer and Anal Dysplasia Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Cidofovir for Perianal Dysplasia in HIV Patients Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
(PQ4) Anal HPV infection and anal HSIL among HIV-infected MSM aged 50+ years Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
The Microbiome and Anal Cancer Pathogenesis in HIV-infected Men who have Sex with Men Joel Palefsky, MD Infectious Disease, HIV/AIDS, Cancer/Oncology
Administrative Supplements to Cancer Centers Support Grants to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries Joel Palefsky, MD HIV/AIDS, Cancer/Oncology, Women's Health
Anal HPV Infection and ASIL in HIV+ and HIV- Women Joel Palefsky, MD HIV/AIDS, Women's Health
California Division Special Research Scholar Grant in HIV-Related Cancers Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
A Master Agreement: HPV Testing of Samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Cancer/Oncology, Women's Health
HPV and AIDS Malignancies Clinical Trials Consortium (AMC) Joel Palefsky, MD HIV/AIDS, Cancer/Oncology
HIV Facilitated Paracellular Penetration of HPV across Mucosal Epithelium Joel Palefsky, MD HIV/AIDS
HIV/HPV cancer prevention treatment and pathogenesis: Rwanda /Einstein Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
HPV testing of samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
Anal Dysplasia SCC Supplement for P30 Cancer Support Grant to Stimulate HIV/AIDS Cancer Research Projects NCI-designated Cancer Centers Joel Palefsky, MD HIV/AIDS, Infectious Disease, Cancer/Oncology
SMART Anal Dysplasia Sub-Study Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
A Phase I, Dose Escalation Study To Establish Safety of Leukocyte Interleukin, Injection [Multikine] for Treatment of Perianal Condylomata In Adult Men and Women Who Are HIV/HPV Co-infected Joel Palefsky, MD HIV/AIDS, Opportunistic Infection, Cancer/Oncology
HPV and Cervix Neoplasia in a Large, Long Term HIV+ Cohort Joel Palefsky, MD HIV/AIDS, Aging
HPV Testing of Samples from the AIDS Malignancy Consortium Joel Palefsky, MD HIV/AIDS
HIV Status and Reproductive Aging Affect Liver Fibrosis in HIV/HCV Infected Women Marion Peters, MD HIV/AIDS, Women's Health
AIDS Clinical Trials Group Network (ACTG) Marion Peters, MD HIV/AIDS
Impact of HIV PMTCT Interventions on HBV Disease in n HIV/HBV Co-infected Women and their Infants Marion Peters, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health
Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Marion Peters, MD HIV/AIDS, Infectious Disease
AIDS Clinical Trials Group (ACTG), TSG Committee Chair funding Marion Peters, MD HIV/AIDS
A Pilot of Intervention to Promote Acute HIV Testing by Ambulatory Care Providers Christopher Pilcher, MD HIV/AIDS
The effects of alcohol on acute HIV associated neurocognitive disorders Christopher Pilcher, MD HIV/AIDS, Dementia and Cognitive Impairment, Substance Abuse
Host Factors Influencing HIV Viral Load and Infectivity in Semen Christopher Pilcher, MD HIV/AIDS, Risk Reduction and Prevention
HIV Incidence Testing using Multiple Biological Specimens Christopher Pilcher, MD HIV/AIDS
Targeting Acute HIV Christopher Pilcher, MD HIV/AIDS, Risk Reduction and Prevention
HIV RNA and/or Antibody Confirmed Positive Plasma Christopher Pilcher, MD HIV/AIDS
HIV Incidence Testing in Hair Christopher Pilcher, MD HIV/AIDS, Drug and Diagnostics Development, Treatment Adherence
Data Collected through the IAVI Early Infection Cohort Study Christopher Pilcher, MD HIV/AIDS
Performance Evaluation of the Bio-Rad Geenius HIV-1/2 Supplemental Assay Christopher Pilcher, MD HIV/AIDS, Drug and Diagnostics Development
Development of Specimen Repository and Evaluation of Assays for Identification of Recent HIV Infection Christopher Pilcher, MD HIV/AIDS
High Throughput Measurement of Envelope Gene Diversity for an HIV Incidence Assay Christopher Pilcher, MD HIV/AIDS, Drug and Diagnostics Development
Antiviral Role of APOBEC3 in HIV/HCV Coinfected Patients HIV/AIDS
Effects of CCR5-D32 Heterozygosity on the HIV-1 Reservoir HIV/AIDS
HIV Molecular Surveillance HIV/AIDS
HIV/AIDS Nursing Care and Prevention Carmen Portillo, RN, PhD, FAAN HIV/AIDS
HIV/AIDS Nursing Care and Prevention Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building
Positive Health: Advanced Nurse Practice Education Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
HIV/AIDS Collaborative Health Model for Nursing Education Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
HIV/AIDS Primary Care Capacity in Nursing (PCC) Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building
HIV/AIDS Primary Care Capacity in Nursing (PCC) Carmen Portillo, RN, PhD, FAAN HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
HIV Proteomics Center for Host Viral Response Characterization Richard Price, MD HIV/AIDS
Central Nervous System HIV Translational Research Training Program Richard Price, MD HIV/AIDS, Neurology and Mental Health, Residencies, Fellowships, and Postdoctoral Training
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Richard Price, MD HIV/AIDS
The Neuropathobiology of Primary HIV-1 Infection Richard Price, MD HIV/AIDS, Neurology and Mental Health
CNS Immune / Inflammatory Biomarkers in HIV Controllers Richard Price, MD HIV/AIDS, Immunology
The Pathobiology of Primary HIV-1 Infection Richard Price, MD HIV/AIDS
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT): START Richard Price, MD HIV/AIDS
HIV Tropism, Persistence, Inflammation, and Neurocognition in Therapy Initiation Richard Price, MD HIV/AIDS, Dementia and Cognitive Impairment
Defining CNS HIV Infection and Its Effects in Treated Patients: Foundation for Eradication Richard Price, MD HIV/AIDS
Compartmentalized CSF viral escape and the CNS HIV reservoir Richard Price, MD HIV/AIDS, Neurology and Mental Health
Malawi Christians and Muslims: HIV Prevention and Care Sally Rankin, FNP, FAAN HIV/AIDS
Evolution and Inhibition of Serine Beta-Lactamase Activity Adam Renslo, PhD Opportunistic Infection, Drug and Diagnostics Development
Identification of Anti-HIV Lead Compounds Targeting Adam Renslo, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Transgender Materials Development E. Michael Reyes, MD, MPH HIV/AIDS, Patient and Peer Education
The Ryan White HIV/AIDS Program Technical Assistance Resources, Guidance, Education, and Training (TARGET) Center: Online Technical Assistance Community E. Michael Reyes, MD, MPH HIV/AIDS
Prevention Umbrella for MSM in the Americas E. Michael Reyes, MD, MPH HIV/AIDS
Perinatal HIV Prevention Services E. Michael Reyes, MD, MPH HIV/AIDS, Labor and Delivery, Newborn and Infant Health
I-TECH International AIDS Education and Training Center E. Michael Reyes, MD, MPH HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building, Training International Scholars and Clinicians
Training and Technical Assistance to Expand HIV Testing in Medical Settings in California's Local Health Jurisdictions (LHD) E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building
Twinning Center E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education
Medical Pharmacy Consultation Team E. Michael Reyes, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
AIDS.gov Microgrant Program E. Michael Reyes, MD, MPH HIV/AIDS, Patient and Peer Education
Perinatal Hospital Training E. Michael Reyes, MD, MPH HIV/AIDS, Women's Health, Newborn and Infant Health
AIDS Education and Training Center E. Michael Reyes, MD, MPH HIV/AIDS, Patient and Peer Education
Medical Pharmacy Consultation Team E. Michael Reyes, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment
International AIDS Education and Training Center E. Michael Reyes, MD, MPH HIV/AIDS, Systematic Reviews and Guideline Development, Health Systems Strengthening, Training and Capacity Building
Improving HIV/AIDS Training and Delivery Services in the Caribbean E. Michael Reyes, MD, MPH HIV/AIDS, Systematic Reviews and Guideline Development, Training and Capacity Building
Democracy Council Technical Assistance program E. Michael Reyes, MD, MPH HIV/AIDS, Policy and Standards of Care
Perinatal Hospital Training E. Michael Reyes, MD, MPH HIV/AIDS, Women's Health, Newborn and Infant Health
Reducing HIV transmission in high prevalence districts in North West Province, Republic of South Africa through Comprehensive and Integrated Mobile Primary Health Services E. Michael Reyes, MD, MPH HIV/AIDS, Training International Scholars and Clinicians
Twinning Center E. Michael Reyes, MD, MPH HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
AIDS Education and Training Center (AETC) E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building
Center of Excellence for Transgender HIV Prevention E. Michael Reyes, MD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
I-TECH UCSF International AETC E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building
The Ryan White HIV/AIDS Program Technical Assistance Resources, Guidance, Education, and Training (TARGET) Center: Online Technical Assistance Community E. Michael Reyes, MD, MPH HIV/AIDS, Patient and Peer Education
The Ryan White HIV/AIDS Program Technical Assistance Resources, Guidance, Education, and Training (TARGET) Center: Online Technical Assistance Community E. Michael Reyes, MD, MPH HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education, Patient and Peer Education
AIDS Education and Training Center E. Michael Reyes, MD, MPH HIV/AIDS, Training and Capacity Building
Establish and maintain a training development unit E. Michael Reyes, MD, MPH HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
International Training and Education Center for Health (I-TECH) E. Michael Reyes, MD, MPH HIV/AIDS, Health Systems Strengthening, Training and Capacity Building
Health Summit E. Michael Reyes, MD, MPH HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training, UCSF Professional Education
Training and Technical Assistance at PAETC- HIV Testing & PrEP E. Michael Reyes, MD, MPH HIV/AIDS, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
Berkeley's Minority Health/Global Health Training Program Philip J. Rosenthal, MD Neglected Tropical Diseases (NTDs), HIV/AIDS, Malaria, Residencies, Fellowships, and Postdoctoral Training
A Prospective Cohort Study of the association between HIV and Malaria Incidence and Response to Antimalarial Therapy in African Children Philip J. Rosenthal, MD HIV/AIDS, Malaria, Pediatrics
A Two-Part, Open-Label, Single-Arm Phase 1/2 Study of Safety, Pharmacokinetics, and Efficacy of Telaprevir in Combination with Peginterferon alfa-2b and Ribavirin in Pediatric Subjects Aged 3 to 17 Infected With Genotype 1 Hepatitis C Virus Infectious Disease, HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics
Protocol AI463-189-004: A Comparative Study of the Antiviral Efficacy and Safety of Entecavir (ETV) HIV/AIDS, Pharmacology and Drug Treatment
HIV Disease Progression in African Children Theodore Ruel, MD HIV/AIDS, Pediatrics
NICHD International & Domestic Pediatric & Maternal HIV Studies Coordinating Center Theodore Ruel, MD HIV/AIDS, Women's Health, Pediatrics
Protocol Development Co-Chair for Phase I/II, Multi-Center, Open-Label Pharmacokinetic, Safety, Tolerability and Antiviral Activity of GSK 1349572, a novel integrase inhibitor, in combination regimens in HIV-1 Infected Infants, Children & Adolescents Theodore Ruel, MD HIV/AIDS, Pharmacology and Drug Treatment, Pediatrics, Adolescent Health
Pediatric AIDS - Primary Care Services Theodore Ruel, MD HIV/AIDS, Pediatrics
LOC-IMPAACT Leadership Group Theodore Ruel, MD HIV/AIDS, Pediatrics, Newborn and Infant Health, Adolescent Health
Uganda METS M&E (Activity A) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
ECHPP Evaluation George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
HIV Prevention for Sero-Discordant Couples George Rutherford, MD HIV/AIDS, Family Planning, Newborn and Infant Health, Policy and Standards of Care, Systematic Reviews and Guideline Development
Late Starter Study George Rutherford, MD HIV/AIDS
HIV Prev Case Management Tech Assistance, Curriculum Dev and Training George Rutherford, MD HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Project SEARCH Nigeria HIV Prevention Project George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Triangulation, Training and Capacity Building
Implementation of The Global Fund's Programmatic Quality Assurance and Improvement Approach George Rutherford, MD HIV/AIDS, Tuberculosis, Malaria
Population-based HIV Impact Assessments in Resource-Constrained Settings under the President's Emergency Plan for AIDS Relief (PEPFAR) George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
UCSF-GSI Technical Assistance in Strategic Information and Health Systems Strengthening under NAM-PHACTS (Program Area C: Strategic Information Activities) George Rutherford, MD HIV/AIDS, Policy and Standards of Care, Epidemiology and Surveillance, Health Systems Strengthening
Zambia Most-at-Risk Populations (MARPS) Surveillance George Rutherford, MD HIV/AIDS
HIV Group Facilitation Curriculum Development and Training George Rutherford, MD HIV/AIDS, Training and Capacity Building
Enhancing Strategic Information Capacity for HIV/AIDS Programs in Kenya through Surveillance and Epidemiology and Monitoring and Evaluation under the U.S. PEPFAR (Program Areas A & B) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building, Training International Scholars and Clinicians
Valley Fever Vaccine Project 2010 George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Global AIDS Technical Assistance Triangulation Project and Case Study in Botswana George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
HIV Measurement, Surveillance & Evaluation Methods Consortium George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Supporting the Implementation and Expansion of High Quality HIV Prevention Care and Treatment Activities and Facility and Community Level in the Republic of Kenya under the President's Emergency Plan for AIDS Relief (PEPFAR) George Rutherford, MD HIV/AIDS, Policy and Standards of Care, Epidemiology and Surveillance, Implementation and Behavioral Science, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building
GH Tech Project: MNCH/FP/HIV George Rutherford, MD HIV/AIDS, Women's Health, Systematic Reviews and Guideline Development
WHO Adolescent Disclosure (PO# 200612583) George Rutherford, MD HIV/AIDS, Adolescent Health, Systematic Reviews and Guideline Development
BCP and HBAC Cost-Effectiveness Analysis George Rutherford, MD HIV/AIDS, Tuberculosis, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Training and Capacity Building, Patient and Peer Education
Uganda METS CBS (Activity C) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
International Traineeships in AIDS Prevention Studies (ITAPS) George Rutherford, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
WHO ART Guidelines - When to Start (PO 200670959) George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development
Programmatic Implementation and Technical Assistance (TA) for HIV/AIDS and Tuberculosis (TB) Prevention, Care and Treatment Services throughout the Health System in South Africa George Rutherford, MD HIV/AIDS, Tuberculosis, Engagement in Care, Treatment Adherence
WHO Adolescent Community-Based Approaches (PO# 200616590) George Rutherford, MD HIV/AIDS, Adolescent Health, Systematic Reviews and Guideline Development
International Traineeships in AIDS Prevention Studies George Rutherford, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians
Guidelines on Health Services Delivery for People with HIV George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development
International Traineeships in AIDS Prevention Studies (ITAPS) George Rutherford, MD HIV/AIDS
Ghana: UCSF Technical Assistance to Support PEPFAR George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
WHO ART Guidelines - What to Use (PO 200671213) George Rutherford, MD HIV/AIDS
WHO Cochrane Project: PMTCT Project George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development
Atlanta HQ: UCSF Technical Assistance to Support PEPFAR George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Global Fund Strategic Review George Rutherford, MD HIV/AIDS, Policy and Standards of Care, Systematic Reviews and Guideline Development, Global Strategic Information
Center for International AIDS Support, Training, and Evaluation (CIASTE) / University Technical Assistance Project in Support of the Global AIDS Program (GAP) George Rutherford, MD HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Impact Evaluation in Malawi George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
Tanzania: UCSF Technical Assistance to Support PEPFAR George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Uganda METS District (Activity B) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
Kenya: Strengthening HIV Strategic Information Activities - Monitoring and Evaluation George Rutherford, MD HIV/AIDS, Global Strategic Information
State Minority AIDS Project 3 (SMAP3) George Rutherford, MD HIV/AIDS
Recent Infection Surveillance Consortium George Rutherford, MD HIV/AIDS, Tuberculosis
TRAINING COURSE in HIV Prevention and Treatment Cascade Analysis George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Epidemiology and Surveillance, Health Systems Strengthening
International AIDS Training Program George Rutherford, MD HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Tanzania: Implementation of Strategic Information Programs for the Prevention, Care, and Treatment of HIV/AIDS for PEPFAR George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information
Support for Male Circumcision Evaluatation Meeting George Rutherford, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Risk Reduction and Prevention
State Minority AIDS Project (SMAP) George Rutherford, MD HIV/AIDS
Uganda METS HMIS (Activity D) George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance, Training and Capacity Building
Valley Fever Vaccine Project George Rutherford, MD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Occupational and Environmental Disease, Drug and Diagnostics Development
Nigeria Monitoring and Evaluation Capacity Building Support George Rutherford, MD HIV/AIDS, Epidemiology and Surveillance
WHO Cochrane Novel Strategies to Prevent MSM HIV/AIDS George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development
WHO Adolescent HTC Review Update (PO# 200660799) George Rutherford, MD HIV/AIDS, Adolescent Health, Systematic Reviews and Guideline Development
Systematic reviews to support the Antiretroviral Therapy (ART) Consolidated Guidelines - 2014/HTM/HIV/007 George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development
WHO Cochrane Project: Systematic Reviews for GRADE Profiles for HIV Infected Children George Rutherford, MD HIV/AIDS, Pediatrics, Systematic Reviews and Guideline Development
Interventions for Improving Retention in Antiretroviral Therapy (ART) Programs (PO 200988865) George Rutherford, MD HIV/AIDS, Systematic Reviews and Guideline Development, Implementation and Behavioral Science, Treatment Adherence, Health Systems Strengthening
Diagnosis, Prevention, and Management of Cryptococcus Infection (Meningeal and Non-Meningeal) George Rutherford, MD Infectious Disease, HIV/AIDS, Opportunistic Infection
Home Based Care Service Assessment Services - Tanzania George Rutherford, MD HIV/AIDS, Engagement in Care
Mozambique Tuberculosis Prevalence Survey (TGF 016-104) George Rutherford, MD HIV/AIDS, Tuberculosis
Technical Assistance to CDC-Ukraine, Network ACCESS-Pro and the Ukrainian Public Health Center George Rutherford, MD HIV/AIDS, Infectious Disease, Transfusion Medicine, Tuberculosis, Health Systems Strengthening, Training and Capacity Building, Training International Scholars and Clinicians
A Mobile Health Application for Engagement in Care among Youth Living with HIV Parya Saberi, PharmD HIV/AIDS, Distance learning and mentoring
Technology-Based Adaptive Treatment Strategies for Antiretroviral Adherence Parya Saberi, PharmD HIV/AIDS, Distance learning and mentoring
Quality of Sleep in HIV-Infection: Association with Treatment and Adherence Parya Saberi, PharmD HIV/AIDS, Pharmacology and Drug Treatment, Treatment Adherence
Rx Pix: A Novel Way to Assess Anti-retroviral Adherence with Pharmacy Refill Dates Parya Saberi, PharmD HIV/AIDS, Engagement in Care, Treatment Adherence
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Ann Schwartz, PhD, MPH HIV/AIDS, Neurology and Mental Health
International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) Ann Schwartz, PhD, MPH HIV/AIDS
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD HIV/AIDS, Transfusion Medicine, Epidemiology and Surveillance
Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) - Central Laboratory Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Transfusion Medicine, Epidemiology and Surveillance
Disease susceptibility and global distribution of genetic variation Mark Seielstad, PhD HIV/AIDS, Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Transfusion Medicine, Genetics, Epidemiology and Surveillance
Inactivation of HIV-1 by Metalloporphyrin Compounds HIV/AIDS
Sheroes Community-Based Research Programs, Center of Excellence for Transgender Health - Girlfriends Connect Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care
A couples-based approach to HIV prevention for transgender women and their male partners Jae Sevelius, PhD HIV/AIDS, Risk Reduction and Prevention
Culturally relevant PrEP demonstration for trans communities Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Mapping perceptions of PrEP use in transwomen and barriers to care in providers to inform intervention development Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care
Improving engagement in HIV care for high-risk women Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care
Sheroes: Culturally Relevant Sexual Risk Reduction among High-Risk Women Jae Sevelius, PhD HIV/AIDS, Stigma and Discrimination
Treatment Engagement and Adherence among HIV+ Transwomen Jae Sevelius, PhD HIV/AIDS, Women's Health
Treatment Engagement and Adherence among HIV+ Transwomen Jae Sevelius, PhD HIV/AIDS, Women's Health
We Are All Women”: Exploring the inclusion of transgender women living with HIV in care and support services for non-transgender women Jae Sevelius, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Culturally Relevant HIV Prevention for High-Risk Women Jae Sevelius, PhD HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Strengthening Mozambican Capacity in Strategic Information Systems under the President's Emergency Plan for AIDS Relief Starley Shade, PhD, MPH HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information, Training and Capacity Building, Training International Scholars and Clinicians
International Maternal Pediatric Adolescent AIDS Clinical Trial Group Master Member Agreement HIV/AIDS, Women's Health, Newborn and Infant Health, Adolescent Health
Tenofovir in Pregnancy (TIP) Study HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award HIV/AIDS, Women's Health, Labor and Delivery, Pediatrics, Newborn and Infant Health
International Maternal Pediatric Adolescent AIDS Clinical Trials Group Leadership Award HIV/AIDS, Women's Health, Pediatrics
International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT) HIV/AIDS, Women's Health, Pediatrics
Pediatric HIV/AIDS Cohort Study (PHACS) Caroline Shiboski, DDS, MPH, PhD HIV/AIDS, Pediatrics
Oral HIV/AIDS Research Alliance at UCSF Caroline Shiboski, DDS, MPH, PhD HIV/AIDS
T003: Oral HIV/AIDS Research Alliance at UCSF Caroline Shiboski, DDS, MPH, PhD HIV/AIDS, Oral Health
HIV-Specific T-Cell Responses in Rectal Mucosa Elizabeth Sinclair, PhD HIV/AIDS, Immunology
HIV-Specific T Cell Responses in Rectal Mucosa Elizabeth Sinclair, PhD HIV/AIDS
Biomarkers of Atherosclerosis Risk in HIV-1 Infection Elizabeth Sinclair, PhD HIV/AIDS
Gender Effects on HIV Biology - Viral Pilot Project HIV/AIDS, Women's Health
Women's HIV Pathogenesis Program/Gender Effects on HIV Biology HIV/AIDS, Women's Health
HPV and Cervix Neoplasia in a Large, Long Term HIV+Cohort HIV/AIDS
Content from UCSF Physicians for SexReally.com J. Joseph Speidel, MD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning, Adolescent Health, Patient and Peer Education
AIDS International Training and Research Program, Consortium Planning Supplement Christopher Stewart, MD HIV/AIDS, Training and Capacity Building
International Clinical Research Fellowship Christopher Stewart, MD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Chronic Respiratory Disease, Diabetes, Occupational and Environmental Disease, Eye Disease and Blindness, Oral Health, Residencies, Fellowships, and Postdoctoral Training
Heat Shock Protein 90 and HIV Persistence HIV/AIDS
Tissue-Based Small Animal Model for HIV Drug Discovery HIV/AIDS
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis Tien, MD Infectious Disease, HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Long-term Effects of IDU, HIV, HCV and the Impact of HCV Cure on Immune Activation and Liver Fibrosis in Aging Women Phyllis Tien, MD Infectious Disease, HIV/AIDS, Immunology, Women's Health
HIV and the Menopausal Transition: Effects on Musculoskeletal Health Phyllis Tien, MD HIV/AIDS, Aging
HIV, HCV, and gender effects on Liver, Bone, and Vascular Health Phyllis Tien, MD Infectious Disease, HIV/AIDS
Sexual Risk of Minority Women and their Male Partners Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Women's Health, Epidemiology and Surveillance, Implementation and Behavioral Science
International Mobility of HIV: ARRA Administrative Supplement Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Epidemiology and Surveillance
HIV Transmission Cluster Analysis to Inform Prevention Hong-Ha Truong, PhD, MS, MPH Infectious Disease, HIV/AIDS, Neurology and Mental Health, Risk Reduction and Prevention
International Mobility of HIV Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Epidemiology and Surveillance
In Our Own Words: Peer-to-Peer Messaging to Increase Uptake of HIV Prevention Strategies among Adolescents in Kenya Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Adolescent Health, Engagement in Care
In Our Own Words: Peer-to-Peer Messaging to Increase Uptake of HIV Prevention Strategies among Adolescents in Kenya Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Adolescent Health, Engagement in Care
HIV Transmission Cluster Analysis to Inform Prevention Hong-Ha Truong, PhD, MS, MPH HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
HIV and HPV Transmission across Mucosal Epithelia Sharof Tugizov, PhD HIV/AIDS
HIV and HPV Transmission Across Mucosal Epithelia Sharof Tugizov, PhD HIV/AIDS, Cancer/Oncology
Role of HIV in acceleration of HPV malignancy Sharof Tugizov, PhD HIV/AIDS, Sexually Transmitted Infections (STIs), Cancer/Oncology
Role of oral herpesvirus microbiota in pathogenesis of HIV mother to child transmission Sharof Tugizov, PhD HIV/AIDS, Labor and Delivery, Newborn and Infant Health
Molecular mechanisms of oral HIV transmission modeling MTCT Sharof Tugizov, PhD HIV/AIDS, Labor and Delivery, Newborn and Infant Health
Molecular Mechanisms of Oral HIV Transmission Modeling MTCT Sharof Tugizov, PhD HIV/AIDS
HIV Transcellular and Transsynaptic Penetration of Mucosal Epithelium Sharof Tugizov, PhD HIV/AIDS
U.S. Army Medical Research Acquisition Activity (USAMRAA) Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health
Interventions for Symptom Management in Older Patients with HAND Victor Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment
Machine learning to distinguish HAND from Alzheimer's disease in HIV over age 60 Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition Victor Valcour, MD, PhD HIV/AIDS, Aging
Midcareer Mentoring Award for Patient-Oriented Research in HIV and Cognition Victor Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment, Residencies, Fellowships, and Postdoctoral Training
Therapeutic Interventions during Acute Infection to Address the CNS Reservoir for HIV Victor Valcour, MD, PhD HIV/AIDS
Dementia in HIV Patients over 60 Years of Age Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health, Dementia and Cognitive Impairment
Central Nervous System Effects in Acute HIV Seroconversion Victor Valcour, MD, PhD HIV/AIDS
Peripheral Reservoir of HIV Monocytes Pivotal to Cognition in HIV Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health, Dementia and Cognitive Impairment
HIV and Global Drug Therapies: Peripheral Neuropathy Complications and Mechanisms Victor Valcour, MD, PhD HIV/AIDS
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT Study Victor Valcour, MD, PhD HIV/AIDS, Neurology and Mental Health, Pediatrics
HIV-1 Specific Immune Responses in Thai Individuals with HIV Dementia Victor Valcour, MD, PhD HIV/AIDS, Dementia and Cognitive Impairment
Microbicide Pregnancy Registry--Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health, Family Planning
Microbicide Pregnancy Registry-Microbicide Trials Network Juan Vargas, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Drug and Diagnostics Development, Women's Health
Aripiprazole Treatment for Methamphetamine Dependence Among High-Risk Men Who Have Sex with Men (MSM) Eric Vittinghoff, PhD HIV/AIDS, Substance Abuse
HOME: A Comprehensive HIV Testing and Linkage Package for Young MSM of Color Eric Vittinghoff, PhD HIV/AIDS, Implementation and Behavioral Science
Aripiprazole Treatment or Methamphetamine Dependence Among High-Risk Men Who Have Sex With Men (MSM) Eric Vittinghoff, PhD HIV/AIDS, Substance Abuse
DOT (Directly observed therapy) Diary Eric Vittinghoff, PhD HIV/AIDS, Tuberculosis
Prevention Umbrella for MSM in the Americas Eric Vittinghoff, PhD HIV/AIDS
Do Differences in Community Viral Load Explain Disparities in HIV Incidence? Eric Vittinghoff, PhD HIV/AIDS, Epidemiology and Surveillance, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Naltrexone for the Treatment of Actively-Using Meth-Dependent MSM with High-Risk Sexual Behavior Eric Vittinghoff, PhD HIV/AIDS, Implementation and Behavioral Science, Substance Abuse
Aripiprazole to Reduce Methamphetamine Use among MSM with High-Risk HIV Eric Vittinghoff, PhD HIV/AIDS, Substance Abuse
Recent Advances in AIDS and HIV Research Paul Volberding, MD HIV/AIDS
CFAR International Scientist Training Awards / International AIDS Training Program Paul Volberding, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
Development of a UCSF-Gladstone CFAR Health Disparities Core Paul Volberding, MD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Fogarty International AIDS Training Paul Volberding, MD HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
CHRP Disparities Initiative: UCSF CFAR Conference Award Paul Volberding, MD HIV/AIDS, Drug and Diagnostics Development, Pharmacology and Drug Treatment
UCSF-Gladstone Center for AIDS Research (CFAR) Paul Volberding, MD HIV/AIDS
Recent Advances in AIDS and HIV Research Paul Volberding, MD HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
UCSF-GIVI Center for AIDS Research (CFAR) Paul Volberding, MD HIV/AIDS, Tuberculosis, Malaria, Cancer/Oncology, Cardiovascular Disease, Drug and Diagnostics Development, Immunology, Pharmacology and Drug Treatment, Neurology and Mental Health, Trauma and PTSD, Women's Health, Pediatrics, Implementation and Behavioral Science, Training and Capacity Building, Training International Scholars and Clinicians
UCSF-GIVI Center for AIDS Research . Paul Volberding, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
UCSF-Gladstone Center for AIDS Research Paul Volberding, MD HIV/AIDS, Neurology and Mental Health, Access or Barriers to Care, Stigma and Discrimination, Training and Capacity Building, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
UAB-UCSF Creative and Novel Ideas in HIV Research Paul Volberding, MD HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training
Grant Agreement #27475 - AIDS 2031: UW-UCSF Research Symposium of HIV in Women Paul Volberding, MD HIV/AIDS, Women's Health
The CFAR Social and Behavioral Science Research Network National Scientific Meeting Paul Volberding, MD HIV/AIDS
amfAR Institute for HIV Cure Research Paul Volberding, MD HIV/AIDS, Drug and Diagnostics Development
Creative and Novel Ideas in HIV Research (UAB Subcontract) Paul Volberding, MD HIV/AIDS
Recent Advances in AIDS and HIV Research Paul Volberding, MD HIV/AIDS
International Maternal Adolescent AIDS Clinical Trials Group - Master Subcontract Diane Wara, MD HIV/AIDS, Women's Health, Pediatrics
NICHD International and Domestic Pediatric and Maternal HIV Studies Coordinating Center Diane Wara, MD HIV/AIDS, Women's Health, Pediatrics
Pediatric AIDS Clinical Trial Group (PACTG) Immunology Core Laboratories Diane Wara, MD HIV/AIDS, Pediatrics
NICHD International and Domestic Pediatric and Maternal HIV Studies Coordinating Center Diane Wara, MD HIV/AIDS, Women's Health, Pediatrics
International Maternal Pediatric Adolescent AIDS Clinical Trial - Leadership Diane Wara, MD HIV/AIDS, Women's Health, Pediatrics
Pediatric AIDS Clinical Trial Group Immunology Core Laboratories Diane Wara, MD HIV/AIDS, Pediatrics
Pathways contributing to racial disparities among HIV clinic cohort patients Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Epidemiology and Surveillance
Women's Interagency HIV (WIHS-V) S. Weiser Sheri Weiser, MD HIV/AIDS, Women's Health
Mechanisms and longitudinal effects of HIV-related stigma on women's adherence and outcomes Sheri Weiser, MD HIV/AIDS, Women's Health, Implementation and Behavioral Science, Treatment Adherence
Food Insecurity: A Key Structural Barrier to HIV/AIDS Care Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Access or Barriers to Care, Implementation and Behavioral Science
Mentoring in Patient Oriented Research on Food Insecurity, HIV and Aging, Weiser K24 Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Exploring the Bidirectional Relationship between Food Security and HIV Treatment Outcomes in a Rural Ugandan Cohort Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Treatment Adherence
Changing Health through Food Support (CHeFS) Program- Expanded Program Sheri Weiser, MD HIV/AIDS, Diabetes, Malnutrition, Micronutrients, Food Insecurity
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Women's Health
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Risk Reduction and Prevention
The Impact of Food Insecurity on HIV Outcomes and Sexual Risk Behavior in Uganda Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Implementation and Behavioral Science, Risk Reduction and Prevention
Pathways from Food Insecurity to Health and Treatment Outcomes in Women with HIV, WEISER CONTINUTATION Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Assessing the preliminary effects of a multisectoral agricultural intervention on the sexual and reproductive health of HIV-affected adolescent girls Sheri Weiser, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Adolescent Health
Effects of Traffic Pollution on Lung Immunity and Pneumonia in Persons with HIV HIV/AIDS, Opportunistic Infection
Documenting the Impact Claire Brindis, DrPH HIV/AIDS
Impact and Cost-effectiveness of Safer Conception Strategies for HIV Prevention Joelle Brown, PhD HIV/AIDS, Women's Health, Family Planning, Health Economics and Effectiveness, Implementation and Behavioral Science, Risk Reduction and Prevention
Impact and Cost-effectiveness of Safer Conception Strategies for HIV Prevention Joelle Brown, PhD HIV/AIDS, Family Planning
Implementation science and reproductive health on sub-Saharan Africa Joelle Brown, PhD HIV/AIDS, Infectious Disease, Sexually Transmitted Infections (STIs), Women's Health, Labor and Delivery, Family Planning
CHAT: mHealth Innovation for HIV-MNCH Community Health Workers in South Africa HIV/AIDS
Agricultural Intervention to Improve Health of HIV-affected Children in Kenya HIV/AIDS
Comparative Effectiveness of Pediatric HIV Disclosure Interventions in Uganda HIV/AIDS
Optimizing HIV counseling testing and referral through an adaptive drug use intervention HIV/AIDS, Engagement in Care
RCT of an integrative intervention for non-treatment-seeking meth users HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Substance Abuse
Evaluation of Harm Reduction Treatment for MSM Who Use Meth HIV/AIDS, Substance Abuse
Research Support for Evaluation of the Positive Resource Center's Employment Services Program HIV/AIDS, Risk Reduction and Prevention
Substance Abuse and HIV/AIDS Prevention Services for At-Risk, Homeless Youth HIV/AIDS, Adolescent Health, Engagement in Care, Substance Abuse, Treatment Adherence
A Pilot Random Control Trial of Expressive Writing with HIV-Positive Methamphetamine Users HIV/AIDS
A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Prophylactic Use of Maribavir Versus Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants Opportunistic Infection, Pharmacology and Drug Treatment
Natural History and Outcomes of Coccidioidomycosis Retrospective Record Review Study Infectious Disease, Opportunistic Infection, Systematic Reviews and Guideline Development
Efficacy and Safety of Eraxis/Ecalta (Anidulafungin) Compared to Cancidas (Caspofungin) in Patients with Candida Deep Tissue Infection: A Phase 4 Study Infectious Disease, HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Protocol # ADMA-001: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial Evaluating the Safety and Efficacy of RI-001 in Medically Immunosuppressed Respiratory Syncytial Virus (RSV) Infected Patients at Risk of Lower Tract RSV HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Phase IV Open-Label, Non-comparative Trial of IV Anidulafungin followed by Oral Azole Therapy for the Treatment of Candidemia and Invasive Candidiasis HIV/AIDS, Opportunistic Infection, Pharmacology and Drug Treatment
Deferasirox (Exjade)-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Opportunistic Infection, Drug and Diagnostics Development
WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi Infectious Disease, Opportunistic Infection, Pharmacology and Drug Treatment
A8851009: A Prospective, Randomized Trial Comparing the Efficacy of Anidulafungin and Voriconazole in Combination to that of Voriconazole Alone When Used For Primary Therapy of Proven or Probable Invasive Aspergillosis Opportunistic Infection, Pharmacology and Drug Treatment
Beyond Pill-Counting: Effect of Pharmacist Counseling on Antiretroviral Adherence Jennifer Cocohoba, PharmD HIV/AIDS, Treatment Adherence
HIV Positive Women's Interactions With Pharmacy System Jennifer Cocohoba, PharmD HIV/AIDS, Women's Health
Strengthening HIV Counselor Training in the Republic of Uganda Philip Darney, MD, MS HIV/AIDS, Women's Health, Training International Scholars and Clinicians, Patient and Peer Education
Economic Opportunity for Zimbabwean Adolescent Orphans Philip Darney, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS
Offering Women with PrEP with Education, shared decision-making and trauma-informed care: the OPENS trial Christine Dehlendorf, MD, MAS HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening
Annual Program Statement for Microbicide Research, Development, and Introduction, Round 2 Tejal Desai, PhD HIV/AIDS, Women's Health, Risk Reduction and Prevention
Human Immunodeficiency Virus (HIV) prevention counseling, oral and blood-based HIV rapid test training for HIV Counselors James Dilley, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education
Trainings for HIV and HCV testing and prevention James Dilley, MD Infectious Disease, HIV/AIDS, Training and Capacity Building
PrEP Navigators Services James Dilley, MD HIV/AIDS, Engagement in Care, Treatment Adherence
UCSF Alliance Health Project (AHP) James Dilley, MD HIV/AIDS
Randomized Trial of Web-Based Support for Evidenced-Based HIV Prevention (PCC) James Dilley, MD HIV/AIDS
Ward 86 Mental Health-GF James Dilley, MD HIV/AIDS, Neurology and Mental Health
Advancing HIV Prevention and Substance Abuse Prevention: HIV Testing Program James Dilley, MD HIV/AIDS
STI Screening as a Combined HIV Prevention Platform for MSM in Peru James Dilley, MD Sexually Transmitted Infections (STIs), HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science, Engagement in Care
Changing HIV Transmission Behavior in HIV-Positive Men James Dilley, MD HIV/AIDS, Risk Reduction and Prevention, Patient and Peer Education
Epie-HIV Surveillance, Agreement Number: 13-10011 James Dilley, MD HIV/AIDS, Epidemiology and Surveillance
TelePCC: Personalized Cognitive Counseling via Phone to Reduce HIV Risk in MSM James Dilley, MD HIV/AIDS, Engagement in Care, Treatment Adherence
AIDS Health Project (AHP) James Dilley, MD HIV/AIDS
UCSF Alliance Health Project--Mission Support James Dilley, MD HIV/AIDS, Engagement in Care, Treatment Adherence
Studies of the Ocular Complications of AIDS (SOCA) Jacque Duncan, MD HIV/AIDS, Eye Disease and Blindness
Statistical methods for clinical trials of novel PrEP agents David Glidden, PhD HIV/AIDS, Pharmacology and Drug Treatment, Systematic Reviews and Guideline Development
Chemoprophylaxis for HIV Prevention in Men Expansion Study [III] David Glidden, PhD HIV/AIDS
Chemoprophylaxis for HIV Prevention in Men Expansion Study [II] David Glidden, PhD HIV/AIDS
Comparison of Pharmacologic Markers of Exposure to HIV Pre-Exposure Prophylaxis David Glidden, PhD HIV/AIDS, Pharmacology and Drug Treatment
Chemoprophylaxis for HIV Prevention in Men Expansion Study [I] David Glidden, PhD HIV/AIDS
Chemoprophylaxis for HIV Prevention: Analysis of Bone and Metabolic Effects David Glidden, PhD HIV/AIDS
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Opportunistic Infection, Women's Health
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Women's Health
Substance Abuse and HIV: Genetics and Disease Progression Ruth Greenblatt, MD HIV/AIDS, Substance Abuse
UCSF-Kaiser Building Interdisciplinary Research Careers in Women's Health Program Ruth Greenblatt, MD HIV/AIDS, Noncommunicable and/or Chronic Disease, Cancer/Oncology, Cardiovascular Disease, Diet, Exercise, and Obesity, Dementia and Cognitive Impairment, Women's Health, UCSF Professional Education
HIV and Adiposity in Women: Effects on Bone Metabolism Ruth Greenblatt, MD HIV/AIDS, Women's Health
Mechanisms of Atherosclerosis and CVD in HIV+ Women Ruth Greenblatt, MD HIV/AIDS, Women's Health
Longitudinal evaluation of HIV-associated lung disease phenotypes Ruth Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Women's Health
The Hair Trigger Study Ruth Greenblatt, MD HIV/AIDS
Gender Effects on HIV Biology Ruth Greenblatt, MD HIV/AIDS, Women's Health
Exploiting Genomic or Nucleomic Information to Understand HIV Latency in Individuals with Substance Use Disorders Ruth Greenblatt, MD HIV/AIDS, Genetics, Substance Abuse
Chicago Women's Interagency HIV Study Consortium (WIHS) Biostatistical Data Analyses Ruth Greenblatt, MD HIV/AIDS, Women's Health, Epidemiology and Surveillance
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Women's Health
The Connie Wofsy Women's HIV Study Ruth Greenblatt, MD HIV/AIDS, Women's Health
Clinical/Data Core WHP-San Francisco Ruth Greenblatt, MD HIV/AIDS, Women's Health, Access or Barriers to Care
The Connie Wofsy Womens' HIV Study Ruth Greenblatt, MD Infectious Disease, HIV/AIDS, Women's Health
Women's Specialty Program Infrastructure Support Contract Ruth Greenblatt, MD HIV/AIDS, Women's Health
Translational evaluation of Aging, Inflammation, and HIV in Lung Dysfunction Ruth Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease, Aging
WIHS Treatment Exposure and Viral Rebound Study / AIDS Research Ruth Greenblatt, MD HIV/AIDS, Women's Health
Prevalence and Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort Ruth Greenblatt, MD HIV/AIDS, Chronic Respiratory Disease, Women's Health
Innovative Methods for Measuring Antiretroviral Exposure Ruth Greenblatt, MD HIV/AIDS
Host Genetics of HIV: Enhancing Discovery through Study Design and New Tools Ruth Greenblatt, MD HIV/AIDS, Genetics
Family Service Networks - Centers of Excellence HIV/AIDS
Evaluation of Adherence to National Guidelines on HIV Prevention for HIV-infected Patients in Clinical Care in Nine US Clinics Who Serve Men Who Have Sex with Men (MSM) HIV/AIDS, Systematic Reviews and Guideline Development, Treatment Adherence, Health Systems Strengthening
Ryan White Title IV Program: Family Services Network HIV/AIDS
HIV Treatment Training for Clinical Setting HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Family Services Network - Ryan White HIV/AIDS Program Infectious Disease, HIV/AIDS, Systematic Reviews and Guideline Development
Chronic Care HIV/AIDS Multi-Disciplinary Program (CCHAMP) HIV/AIDS
VX11-950-115 An Open Label, Phase 3 Study of Telaprevir in Combination With Peginterferon Alfa 2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Coinfected With Genotype 1 Hepatitis C Virus and Human Immunodeficiency Virus Type 1(HCV/HIV-1) Sexually Transmitted Infections (STIs), HIV/AIDS
Abbott Preceptorship HIV/AIDS
She's Living Positive Health Fair HIV/AIDS, Patient and Peer Education
Darpun Sachdev mentored participation in HIV Clinical Trials HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Treatment of Acute Hepatitis C Virus in HIV Co-Infection Sexually Transmitted Infections (STIs), HIV/AIDS
African American Center of Excellence HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Health Systems Strengthening, Patient and Peer Education
Primary Care Services- Non Severe Need - Ward 86 HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) HIV/AIDS, Access or Barriers to Care, Health Systems Strengthening
Hepatitis C Co-infection Clinic: A to T (Acute to Transplant) Sexually Transmitted Infections (STIs), HIV/AIDS
Expanded HIV Testing for Disproportionately Affected Population HIV/AIDS
Outpatient Services Ward 86 HIV/AIDS
CHRP for Integrating HIV and Geriatric for People Living with HIV 50 and Over HIV/AIDS, Engagement in Care, Health Systems Strengthening
Study of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Subjects Who Have Chronic HCV-1/HIV-1 Co-Infection and Are Treatment-Naïve for Hepatitis C Infectious Disease, HIV/AIDS
Ward 86 Outpatient Services / Perinatal Services HIV/AIDS, Women's Health, Newborn and Infant Health
The Use of Nelfinavir During Acute or Early HIV Infection - Safety, Tolerability, Durablilty and Resistance HIV/AIDS, Pharmacology and Drug Treatment
Women's Center of Excellence HIV/AIDS, Women's Health, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Patient and Peer Education
Ward 86 Outpatient Services/Perinatal Services HIV/AIDS, Patient and Peer Education
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) HIV/AIDS, Neurology and Mental Health
HIV Health Services - Program Database Services HIV/AIDS
Ryan White Title IV Program: Integrated Family Services Network / AIDS-related HIV/AIDS
Chronic Care HIV/AIDS Multidisciplinary Program (CCHAMP) Center of Excellence HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, UCSF Professional Education, Patient and Peer Education
Sexual Harm Reduction for HIV+ Gay Men (Prevention with Positives) HIV/AIDS, Risk Reduction and Prevention
Stored Blood Specimens HIV/AIDS
Ward 86 Outpatient Services/Perinatal Services HIV/AIDS, Newborn and Infant Health
Positive Health Access to Services and Treatment (PHAST) HIV/AIDS
Positive Health Access to Service and Treatment (PHAST) HIV/AIDS, Engagement in Care
Providers' Perceptions of the Diaphragm in Southern Africa and the United States Cynthia Harper, PhD Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Training International Scholars and Clinicians, UCSF Professional Education
Consultation with the Hektoen Institute, Chicago WIHS Nancy Hessol, MSPH HIV/AIDS, Women's Health
HOME: A Comprehensive HIV Testing and Linkage Package for Young MSM of Color Nancy Hessol, MSPH HIV/AIDS, Access or Barriers to Care, Engagement in Care, Risk Reduction and Prevention
Enhancing PrEP in Community Settings (EPIC) Nancy Hessol, MSPH HIV/AIDS, Treatment Adherence
Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons Nancy Hessol, MSPH HIV/AIDS, Cancer/Oncology
Consultation with the SFDPH HIV/AIDS surveillance unit Nancy Hessol, MSPH HIV/AIDS, Epidemiology and Surveillance
Consultation with the SFDPH HIV/AIDS surveillance unit Nancy Hessol, MSPH HIV/AIDS
Out Patient Mental Health Support Group for Heterosexual Identified HIV+ African American Men [I] HIV/AIDS, Engagement in Care, Treatment Adherence, Patient and Peer Education
UCSF/PHP Men of Color Program (MOCP) HIV/AIDS, Patient and Peer Education
Pilot Telehealth Project to Increase Access to Health Services for African American Men Living with HIV or AIDS HIV/AIDS, Engagement in Care
Southeast Partnership for Health, Center of Excellence HIV/AIDS
360: The Positive Care Center - Men of Color Program (MOCP) - Integrated Case Management HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care, Treatment Adherence
UCSF/PHP Men of Color Program Outreach Worker Program HIV/AIDS, Access or Barriers to Care
HPV-Specific T Cell Responses and Anogenital HPV Disease in Women of the WIHS HIV/AIDS, Cancer/Oncology, Women's Health
HOME: A Comprehensive HIV Testing and Linkage Package for Young MSM of Color HIV/AIDS
UCSF/PHP Men of Color Program - Outreach Worker Program HIV/AIDS, Patient and Peer Education
Creating a Specialized Patient-Centered Medical Home for Persons 50 and Older Living with HIV/AIDS HIV/AIDS, Health Economics and Effectiveness, Implementation and Behavioral Science, Treatment Adherence, Health Systems Strengthening
Sexual Reproductive Health/HIV Linkages Evidence Project HIV/AIDS
WHO Cochrane Project: Antiretroviral Therapy Project HIV/AIDS
Pathogenesis of HIV-Related Bacillary Angiomatosis HIV/AIDS, Opportunistic Infection, Infectious Disease, Cancer/Oncology
Mechanisms of Bartonella Virulence in AIDS Patients HIV/AIDS, Cancer/Oncology, Risk Reduction and Prevention
Mechanisms of Bartonella Virulence in AIDS Patients HIV/AIDS
Bartonella Virulence Mechanisms in Patients with AIDS Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS
Bartonella: dissecting niche-specific adaptation in a human pathogen Opportunistic Infection
Global Innate Immune Responses to HIV-1 Infection Nevan Krogan, PhD, MSc HIV/AIDS, Immunology
A systems-level approach in HIV/AIDS susceptibility and substance abuse Nevan Krogan, PhD, MSc HIV/AIDS, Substance Abuse
HINT: HIV Immune Networks Team Modeling Core Nevan Krogan, PhD, MSc HIV/AIDS, Immunology
Pain and Misuse of Prescription Opioids in a Community-Based HIV-Infected Cohort Margot Kushel, MD HIV/AIDS
A Random Control Trial (RCT) of HIV Adherence Case Management and Modified DOT Margot Kushel, MD HIV/AIDS, Neurology and Mental Health, Substance Abuse
International HIV ARV Adherence, Resistance and Survival (REACH) Margot Kushel, MD HIV/AIDS, Treatment Adherence
North American AIDS Cohorts Collaboration on Research and Design Margot Kushel, MD HIV/AIDS
Probing Below the Surface: Development of a Molecular Diagnostic Assay to Detect Emergent Viral Escape Variants HIV/AIDS, Drug and Diagnostics Development
Ultra-Low Viral Detection Using the Abbott RealTime HIV-1 Assay HIV/AIDS, Drug and Diagnostics Development
Ultrasensitive Monitoring of HIV-1 Drug Resistance Reversion Following Transmission with Drug Resistant Virus HIV/AIDS, Pharmacology and Drug Treatment, Women's Health, Newborn and Infant Health
Disclosure Intervention for Zimbabwean Parents: Y 4 RPPR processed as renewal for P subaccount transition HIV/AIDS, Stigma and Discrimination, Patient and Peer Education
A Comprehensive Community-based Strategy to Optimize the HIV Prevention and Treatment Continuum for Youth At HIV Risk, Acutely Infected and with Established HIV Infection HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Center for AIDS Prevention Studies HIV/AIDS, Engagement in Care, Substance Abuse, Treatment Adherence, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
Disclosure Intervention for Zimbabwean Parents HIV/AIDS, Risk Reduction and Prevention
Computer-Based versus Interpersonal HIV Preventive Intervention for Delinquent Youth HIV/AIDS
Maintenance Strategies for Homeless Youth's Reductions in HIV Risk Acts HIV/AIDS, Adolescent Health, Risk Reduction and Prevention
Substance Use and HIV Prevention Research in Minority Communities Training Program HIV/AIDS, Residencies, Fellowships, and Postdoctoral Training
Recruiting, Engaging, and Retaining Families for Interventions to Prevent HIV Transmission and Infection in Delinquent African American Adolescents on Probation HIV/AIDS, Engagement in Care, Treatment Adherence
Strong African American Families (SAAF) HIV Prevention Program HIV/AIDS
UCSF Prevention Research Center HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention, Patient and Peer Education
Networked Home HIV Testing HIV/AIDS, Access or Barriers to Care, Patient and Peer Education
Social Media Messaging for HIV Testing in Zimbabwe HIV/AIDS, Access or Barriers to Care, Engagement in Care
Substance Use and HIV Prevention Research in Minority Communities Training Program HIV/AIDS, Substance Abuse
Technology to Connect At-Risk Youth to Testing HIV/AIDS, Implementation and Behavioral Science
Come As You Are - Assessing the Efficacy of a Nurse Case Management HIV Prevention and Care Intervention among Homeless Youth HIV/AIDS, Engagement in Care, Treatment Adherence, Risk Reduction and Prevention
Home Testing: Transformative Research HIV/AIDS
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Coordinating Center HIV/AIDS
Infrastructure For Community-Linked Research To Address Disparities in HIVAIDS HIV/AIDS
Strong African American Families (SAAF) HIV Prevention Program HIV/AIDS
Implementation science, and behavioral interventions in support of HIV prevention Christina (Krysia) Lindan, MD, MSc HIV/AIDS, Implementation and Behavioral Science
HSV-2 Avidity Testing for Intervention for Male Sexually-Transmitted Disease (STD) Patients in India Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
HIV/AIDS and Family Planning/Reproductive Health Linkages Christina (Krysia) Lindan, MD, MSc HIV/AIDS, Women's Health, Family Planning
Sustaining Vietnam's First Anonymous HIV Testing and Counseling Center Christina (Krysia) Lindan, MD, MSc HIV/AIDS, Health Economics and Effectiveness, Access or Barriers to Care, Stigma and Discrimination
Provision of Technical Assistance to Strengthen HIV Strategic Information Activities Christina (Krysia) Lindan, MD, MSc HIV/AIDS, Systematic Reviews and Guideline Development
An Intervention for Male STD Patients in India / HIV Related Christina (Krysia) Lindan, MD, MSc Sexually Transmitted Infections (STIs), HIV/AIDS
Enhancing HIV Testing, Linkage to Care and Partner Services in San Francisco HIV/AIDS, Risk Reduction and Prevention
CRUSH: Connecting Resources for Urban Health HIV/AIDS, Patient and Peer Education
Evaluation and Technical Assistance Center for the Special Projects of National Significance (SPNS) Systems Linkages Initiative HIV/AIDS, Access or Barriers to Care
AIDS Education and Training Centers (AETC) National Evaluation Center (NEC) HIV/AIDS, Health Economics and Effectiveness
Social Media Evaluation and Technical Assistance Center HIV/AIDS
East Bay Test and Connect HIV/AIDS, Engagement in Care
Health Information Technology Evaluation and Support Center: Evaluation and Support Center for An Initiative on Information Technology Networks of Care HIV/AIDS
Evaluating the Implementation of the CDC's Revised Recommendations for HIV Testing in U.S. Healthcare Settings HIV/AIDS, Systematic Reviews and Guideline Development, Implementation and Behavioral Science
Culturally Appropriate Interventions of Outreach, Access HIV/AIDS, Access or Barriers to Care, Engagement in Care
Using Evidence Informed Interventions to Improve Health Outcomes among People Living with HIV Evaluation HIV/AIDS
AIDS Education and Training Centers (AETC) National Evaluation Center (NEC) HIV/AIDS, Training International Scholars and Clinicians, Residencies, Fellowships, and Postdoctoral Training, Patient and Peer Education
Navigator Enhanced Case Management for Jail Inmates HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Navigator Enhanced Case Management for Jail Inmates HIV/AIDS
Crush: Connecting Resources for Urban Sexual Health HIV/AIDS
METIDA- M&E related Technical Assistance and Improved Data Application in HIV HIV/AIDS
Structural Biology and Targeted Drug Design for AIDS HIV/AIDS, Drug and Diagnostics Development
Evaluation of Web Based HIV Risk Behavior Surveillance Among Men Who Have Sex With Men HIV/AIDS, Patient and Peer Education
Transgender Evaluation and Technical Assistance Center HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Capacity Building Assistance (CBA) to Improve the Delivery and Effectiveness of HIV Prevention HIV/AIDS
Transgender Evaluation and Technical Assistance Center HIV/AIDS, Access or Barriers to Care
Increasing the Capacity of Community Based Organizations to Conduct High-Impact HIV Prevention HIV/AIDS, Patient and Peer Education
Public Health Conference Support for the 2017 UCSF National Transgender Health Summit HIV/AIDS, UCSF Professional Education
Community Based Organization Behavioral Outcome Project (CBOP) HIV/AIDS, Implementation and Behavioral Science
Public Health Conference Support for the 2019 UCSF National Transgender Health Summit HIV/AIDS, Stigma and Discrimination
HIV Risk Reduction for Women with Incarcerated Partners HIV/AIDS
Networking and Mentoring Meeting: HIV Prevention in Minority Communities Program HIV/AIDS
HIV and STD Intervention Research for Young Men in Prison HIV/AIDS, Access or Barriers to Care
Environment and HIV Risks among Unstably Housed Women Elise Riley, PhD HIV/AIDS, Women's Health, Access or Barriers to Care
Effects of Housing and HIV on Risk Behavior and Victimization of Indigent Women Elise Riley, PhD HIV/AIDS, Women's Health
Drugs, Gender and Healthcare Use among HIV+ Homeless Elise Riley, PhD HIV/AIDS, Neurology and Mental Health, Substance Abuse
Updating HCV treatment engagement paradigms for HIV/HCV coinfected patients Elise Riley, PhD Infectious Disease, HIV/AIDS, Engagement in Care
Mentoring patient-oriented research on the health consequences of polydrug use Elise Riley, PhD HIV/AIDS, Cardiovascular Disease, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Substance Abuse, Training and Capacity Building
Host-pathogen Interactions during Vertical Transmission of Listeria monocytogenes Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection, Women's Health, Labor and Delivery, Newborn and Infant Health
Pharmacostatistical Modeling and Simulation of Randomized Clinical PrEP Trials Rada Savic, PhD HIV/AIDS, Systematic Reviews and Guideline Development, Treatment Adherence
Clinical Trial Simulation efforts for upcoming HIV therapeutic development. Rada Savic, PhD HIV/AIDS
Development of Rectal Enema As Microbicide (DREAM) Rada Savic, PhD HIV/AIDS, Pharmacology and Drug Treatment
A Randomized Controlled Trial Evaluating Locally Administered Gentamicin in the Prevention of Deep Infection after Open Tibial Shaft Fractures in Tanzania David Shearer, MD Opportunistic Infection, Surgery and Anesthesia, Pharmacology and Drug Treatment
AIDS Policy Research Center Wayne Steward, PhD, MPH HIV/AIDS, Policy and Standards of Care
Evaluation of SFAF's Magnet Program Wayne Steward, PhD, MPH HIV/AIDS, Patient and Peer Education
System-level Workforce Capacity Building for Integrating HIV Primary Care in Community Healthcare Settings - Evaluation and Technical Assistance Center Wayne Steward, PhD, MPH HIV/AIDS, Training and Capacity Building, Residencies, Fellowships, and Postdoctoral Training
AIDS Policy Research Center Wayne Steward, PhD, MPH HIV/AIDS, Policy and Standards of Care
Evaluation of SFAF's Magnet Program Wayne Steward, PhD, MPH HIV/AIDS, Patient and Peer Education
AIDS Policy Research Center Wayne Steward, PhD, MPH HIV/AIDS, Policy and Standards of Care
AIDS Policy Research Center Wayne Steward, PhD, MPH HIV/AIDS, Policy and Standards of Care
Expanding the Role of Nursing in the Care of HIV/AIDS in Tanzania HIV/AIDS
A Clinical Trial of DOT for HAART in Jailed Drug Users / AIDS Related Jacqueline Tulsky, MD HIV/AIDS
Crossing Boundaries: Continuity of Medical Care for Incarcerated Adults Jacqueline Tulsky, MD HIV/AIDS, Access or Barriers to Care
Randomized Controlled Trial of 6% Cellulose Sulfate Gel and the Effect on Vaginal HIV Transmission Ariane Van der Straten, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Pharmacology and Drug Treatment
A Social Marketing Approach to Increase HIV Testing among High-Risk Men in China Chongyi Wei, DrPH HIV/AIDS, Implementation and Behavioral Science, Risk Reduction and Prevention
Spurring Innovation in HIV Testing and Linkage: A Crowdsourcing Approach Chongyi Wei, DrPH HIV/AIDS, Engagement in Care
Development of an HIV Self-testing Intervention to Reduce HIV risks among MSM: Taking the Guess Out of Seroguessing Chongyi Wei, DrPH HIV/AIDS, Access or Barriers to Care, Engagement in Care
Population-based Screening and Brief Intervention in Primary Care: Health and Drinking Outcomes, Cost and Utilization Constance Weisner, DrPH HIV/AIDS, Substance Abuse
Host Genetic Predictors of IDO-induced Tryptophan Catabolism Among HIV-Infected Ugandans Maintaining Treatment-Mediated Viral Suppression Sulggi Lee, MD HIV/AIDS
A Pharmacogenomics Study of HIV Latency: The Role of Anti-Programmed Cell Death-1 (PD-1) Signaling Sulggi Lee, MD HIV/AIDS, Immunology
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease Sulggi Lee, MD HIV/AIDS, Substance Abuse
Study of the Cost and Efficiency of HIV Prevention in Developing Countries James Kahn, MD, MPH HIV/AIDS, Health Economics and Effectiveness
Building Capacity in the Estimation of Unmet Need for HIV Care James Kahn, MD, MPH HIV/AIDS, Epidemiology and Surveillance
A Phase III Multicenter Randomized Study of the Biological and Clinical Efficacy of Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts (SILCAAT) James Kahn, MD, MPH HIV/AIDS, Pharmacology and Drug Treatment, Health Economics and Effectiveness
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse James Kahn, MD, MPH HIV/AIDS, Tuberculosis, Health Economics and Effectiveness
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse James Kahn, MD, MPH HIV/AIDS, Health Economics and Effectiveness, Substance Abuse
Global Health Comparative Effectiveness: A Data Synthesis Method Applied to HIV James Kahn, MD, MPH HIV/AIDS, Health Economics and Effectiveness
High-Quality, High Volume Cataract Surgery at Aravind as a Model for Male Circumcision James Kahn, MD, MPH HIV/AIDS, Surgery and Anesthesia, Risk Reduction and Prevention
Making Better Decision: Policy Modeling for AIDS and Drug Abuse [I] James Kahn, MD, MPH HIV/AIDS, Health Economics and Effectiveness, Substance Abuse
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse [II] James Kahn, MD, MPH HIV/AIDS, Health Economics and Effectiveness
HIV prevention among female sex workers in Kampala, Uganda Rachel King, PhD, MPH HIV/AIDS, Stigma and Discrimination, Risk Reduction and Prevention
A cognitive behavioral and structural HIV prevention intervention for young Ugandan women engaging in high risk sexual behavior Rachel King, PhD, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Risk Reduction and Prevention
Comparative Effectiveness of Pediatric HIV Disclosure Interventions in Uganda Rachel King, PhD, MPH HIV/AIDS, Pediatrics, Health Economics and Effectiveness, Engagement in Care, Treatment Adherence, Health Systems Strengthening, Training International Scholars and Clinicians
The Impact of Health Care Reform on Addiction and HIV Services HIV/AIDS
Implementing computerized substance use and depression screening and evidence-based treatments in an HIV primary care population HIV/AIDS
The Impact of Health Care Reform on Addiction and HIV Services HIV/AIDS, Substance Abuse
Mentoring alcohol use intervention research in health care settings HIV/AIDS, Substance Abuse
Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients HIV/AIDS, Substance Abuse
2/3 COMpAAAS Tripartite: ART-CC, KP, and VA HIV/AIDS
Epidemiology capacity building Nancy Hills, PhD HIV/AIDS, Infectious Disease, Epidemiology and Surveillance
AHEC/HETC - California Border Health Education Training Center HIV/AIDS, Training and Capacity Building
Collaboration with Infectious Disease institute in Kampala Uganda Warner Greene, MD, PhD HIV/AIDS, Health Systems Strengthening, Training and Capacity Building
PPG Development and Management Services Warner Greene, MD, PhD HIV/AIDS
Magnet Readiness Program HIV/AIDS
Microbiome, Virome, and Host Responses Preceding Ventilator-Associated Pneumonia (VAP) Opportunistic Infection, Occupational and Environmental Disease, Pediatrics
Alcohol and Condom Use among HIV+ Ugandan Adults: a Prospective Event-Level Study Sarah Woolf-King, PhD, MPH HIV/AIDS, Substance Abuse
Alcohol Use and High Risk Behavior Among HIV-Positive Men Sarah Woolf-King, PhD, MPH HIV/AIDS, Substance Abuse
Role of Monocyte Oxidative Stress and Mineralocorticoid Receptor Signaling on Cardiovascular Disease and Persistent Inflammation in Antiretroviral-Treated HIV+ Persons HIV/AIDS, Cardiovascular Disease
The Social Context of HIV Post-Exposure Prophylaxis (PEP) HIV/AIDS, Neurology and Mental Health
Behavioral, Basic, and Clinical Studies of PEP HIV/AIDS, Implementation and Behavioral Science
Pharmacokinetics and tolerability of adjunctive linezolid for the treatment of tuberculous meningitis Felicia Chow, MD HIV/AIDS, Tuberculosis, Drug and Diagnostics Development, Pharmacology and Drug Treatment
Leadership and Operations Center, AIDS Clinical Trials Group Felicia Chow, MD HIV/AIDS
A feasibility study of the transcranial Doppler breath-holding challenge to evaluate cerebral vasoreactivity in HIV-infected individuals in China Felicia Chow, MD HIV/AIDS, Neurology and Mental Health
Cerebrovascular mechanisms of HIV-associated cognitive impairment in China Felicia Chow, MD HIV/AIDS, Neurology and Mental Health
Multidisciplinary NeuroAIDS Research Training to Improve HIV Outcomes in Nigeria Felicia Chow, MD HIV/AIDS, Training International Scholars and Clinicians, Patient and Peer Education
The Neuropathobiology of Primary HIV-1 Infection HIV/AIDS, Neurology and Mental Health
The Neuropathobiology of Primary HIV-1 Infection HIV/AIDS, Neurology and Mental Health
Central Nervous System Events in Primary HIV Infection Infectious Disease, HIV/AIDS, Neurology and Mental Health
Evaluation of the Population-level Impact of PMTCT Option B+ Implemented in Zimbabwe HIV/AIDS, Women's Health, Pediatrics, Treatment Adherence, Risk Reduction and Prevention
External Evaluation of Elizabeth Glaser Pediatric AIDS Foundation's Prevention of Mother to Child Transmission of HIV Programme in Zimbabwe HIV/AIDS, Women's Health, Labor and Delivery, Newborn and Infant Health, Risk Reduction and Prevention
Elucidating the mechanism of macrophage death during infection with the AIDS-associated opportunistic pathogen Histoplasma capsulatum Anita Sil, MD, PhD HIV/AIDS, Opportunistic Infection
Gene circuits that control morphology in Histoplasma Anita Sil, MD, PhD Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
Gene Circuits that Control Morphology in Histoplasma Anita Sil, MD, PhD Infectious Disease, Opportunistic Infection
Proteomics Analysis of Host-Pathogen Interactions in Histoplasma Anita Sil, MD, PhD Opportunistic Infection, Immunology
UCSF-GIVI CFAR East Africa Regional Director HIV/AIDS, Tuberculosis, Malaria, Training and Capacity Building, Training International Scholars and Clinicians
Biomarkers that Predict the Response of AIDS-Related Kaposi's Sarcoma to Antiretroviral Therapy and the Risk of Developing Immune Reconstitution Inflammatory Syndrome HIV/AIDS, Cancer/Oncology
The Incidence of Bacillary Angiomatosis in Uganda Infectious Disease, Zoonosis, Emerging Disease, and Drug Resistance, Opportunistic Infection
The Zimbabwe-San Francisco HIV Prevention Trials Unit HIV/AIDS
A Randomized Placebo-Controlled Trial to Evaluate the Effectiveness of Antiretroviral Therapy to Reduce Transmission of HIV-1 in Serodiscordant Couples HIV/AIDS, Women's Health, Family Planning, Risk Reduction and Prevention
Hormonal Contraception and the Risk of HIV Acquisition HIV/AIDS, Family Planning
Preventing HIV by Protecting the Cervix HIV/AIDS, Women's Health
Microbicides Trials Network HIV/AIDS, Women's Health
Coming Together to Overcome HIV/AIDS in Zimbabwe and Zambia HIV/AIDS
A Phase I Safety Trial of the Diaphragm in Zimbabwe Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Family Planning
HIV Prevention Trials Network (HPTN) Executive Committee HIV/AIDS
Zimbabwe San Francisco HPTN Fogarty Training / International AIDS Training Program HIV/AIDS, Women's Health
International AIDS Training Program HIV/AIDS
Multi-Locus Sequence Typing Environmental Fungal Samples from Western Kenya Opportunistic Infection, Occupational and Environmental Disease
Addressing Health Disparities among Transgender Women Rachel Kaplan, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Gender Based Violence and HIV Outcomes-Tracking and Treating Mental Illness Susan Meffert, MD, MPH HIV/AIDS, Neurology and Mental Health, Trauma and PTSD, Women's Health
Evaluation of Novel Tuberculosis Screening Strategies for People living with HIV Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Point-of-care C-reactive protein-based tuberculosis screening among people living with HIV: planning a comparative effectiveness trial Christina Yoon, MD, MPH HIV/AIDS, Tuberculosis
Understanding the Interpersonal Context of HIV/HCV risk within Injecting Dyads Meghan Morris, PhD, MPH Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Cancer/Oncology
Individual, social, and structural factors on disease transmission in marginalized populations Meghan Morris, PhD, MPH HIV/AIDS, Infectious Disease, Access or Barriers to Care
Tanzania UCSF Technical assistance to Support PEPFAR Meghan Morris, PhD, MPH HIV/AIDS, Epidemiology and Surveillance
Award - Development of a Social Network-enhanced Adherence Intervention for PrEP in Young African Women Catherine Koss, MD HIV/AIDS, Treatment Adherence
Understanding HIV Pre-exposure Prophylaxis Engagement among Women in East Africa Catherine Koss, MD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination
Retention in Care and Virologic Suppression among Childbearing HIV-Infected Ugandan Women in the Era of Lifelong Combination Antiretroviral Therapy Catherine Koss, MD HIV/AIDS, Women's Health, Pediatrics
Intergovernmental Personnel Agreement (IPA) Eric Goosby, MD HIV/AIDS, Tuberculosis
STE SI - Technical Assistance to develop a HIV specific annex for the Sustainability,Transition, and Co-financing Guidance Note through UCSF IGHS Eric Goosby, MD HIV/AIDS
Strategic Partnership Alliance - Born Free and UCSF Eric Goosby, MD HIV/AIDS, Women's Health, Pediatrics, Newborn and Infant Health
Cambodia Integrated HIV and Drug Prevention Implementation Ellen Stein, MPH Sexually Transmitted Infections (STIs), HIV/AIDS, Women's Health, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Recurrence of CIN2+ among HIV-infected women in Kisumu, Kenya two years after treatment with LEEP Keerthana Anand, MS HIV/AIDS, Cancer/Oncology, Women's Health
Surveilling the syndemic: Assessment of an integrated tuberculosis and HIV pilot surveillance system in Haiti Kristiana Dhillon, MS HIV/AIDS, Tuberculosis
Shamba Maisha: Qualitative Evaluation of the Mental Health Impacts of a Multisectoral Livelihood Intervention for Food Security and HIV Outcomes in Kenya Kathryne Doria, MS HIV/AIDS, Neurology and Mental Health
Investigating Interventions for Increasing Uptake of Prevention of Mother-to-Child HIV Transmission Services: A Systematic Review Veesta Falahati, MS HIV/AIDS, Women's Health, Labor and Delivery, Newborn and Infant Health
Reactivation of latent HIV using recombinant galectin-9 HIV/AIDS, Immunology
How well do six hospitals offering PMTCT services in rural Cross River Nigeria perform on multiple Health care quality indicators for PMTCT? A quality Improvement study Joel Igu, MS HIV/AIDS, Women's Health, Labor and Delivery, Pediatrics, Newborn and Infant Health, Implementation and Behavioral Science, Treatment Adherence, Risk Reduction and Prevention
Methodological and Analysis approaches in Sexual Networking Studies of HIV/AIDS; A Systematic Review Ashley Lucas, MS HIV/AIDS, Epidemiology and Surveillance
Determinants of Unprotected Receptive Anal Intercourse Among Trans Feminine Individuals in Beirut, Lebanon Justine McGowan, MS HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Epidemiology and Surveillance
Client satisfaction and community perception of the GAIA mobile health clinics in southern rural Malawi: A mixed methods study Amy Sacco, MS HIV/AIDS, Engagement in Care, Health Systems Strengthening, Training and Capacity Building
HIV-associated neurocognitive impairment and antiretroviral adherence: secondary data analysis of the THINK2 prospective cohort study Laura Saucier, MS HIV/AIDS, Dementia and Cognitive Impairment
The impact of follow-up care on HIV-infected individuals in the Mulanje district, Malawi: a qualitative study Nicole Schouwenaar, MS HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Process Evaluation of a Community-Based Participatory Design of Mobile Health Technology to Address Risk Factors for Depression Among Caregivers of HIV-Affected Children in South Africa Daniel Schrader, MS HIV/AIDS, Neurology and Mental Health, Access or Barriers to Care
Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda Carina Marquez, MD HIV/AIDS, Tuberculosis, Pediatrics, Epidemiology and Surveillance
Capacity Based Assistance (CBA) for High Impact HIV Prevention to Health Departments in the United States HIV/AIDS, Training and Capacity Building
Continuum of HIV Prevention Care Services HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
Development of an integrated contraception and HIV prevention decision support tool for family planning clients in Kisumu, Kenya Dominika L. Seidman, MD HIV/AIDS, Family Planning
Integration of pre-exposure prophylaxis education at family planning clinics Dominika L. Seidman, MD HIV/AIDS, Patient and Peer Education
Women's HIV Program at UCSF Edward Machtinger, MD HIV/AIDS, Women's Health
The Women's HIV Program at UCSF & Rhodessa Jones Edward Machtinger, MD HIV/AIDS, Women's Health
Health, Empowerment, and Recovery Services (HERS) Program Edward Machtinger, MD HIV/AIDS, Substance Abuse
Classification in the Public Provision of Care: Trans Health in North and South America Janet K. Shim, PhD HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
START: Study of Trauma and Reduction of HIV Transmission HIV/AIDS, Trauma and PTSD, Implementation and Behavioral Science, Substance Abuse
Targeted Treatment of Early Cryptococcal Infection in HIV-infected Patients HIV/AIDS, Opportunistic Infection
Using Information to Align Services and Link and Retain Men in the HIV Cascade Shari L. Dworkin, PhD, MS HIV/AIDS, Engagement in Care, Patient and Peer Education
MSM and Gay Male Relationship Power Shari L. Dworkin, PhD, MS HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Treatment Adherence
Defining the clinical utility of CSF biomarkers of neurodegeneration in HIV+ elders HIV/AIDS, Neurology and Mental Health
ComHealth: Cost-effective mHealth strategy to improve long-term retention in HIV care for mother-baby pairs HIV/AIDS, Women's Health, Newborn and Infant Health, Health Economics and Effectiveness, Treatment Adherence
An economic and relationship-strengthening intervention for HIV-affected couples who drink alcohol in Malawi Amy Conroy, PhD HIV/AIDS, Substance Abuse, Treatment Adherence
Exploring Relationship Factors and Engagement in HIV Care in South Africa Amy Conroy, PhD HIV/AIDS, Engagement in Care
Consultancy for design support for Unitaid's Initiative on Advanced HIV Disease Colin Boyle, MPP, MBA HIV/AIDS, Access or Barriers to Care
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs HIV/AIDS, Drug and Diagnostics Development
Impact of Chemotherapy and Stem Cell Transplant on HIV-1 Reservoir Dynamics HIV/AIDS, Drug and Diagnostics Development
An Ultrasensitive in Vivo Latent HIV Viral Outgrowth Assay Using Humanized Mice HIV/AIDS, Drug and Diagnostics Development
Single Cell Characterization of Latent HIV-1 Reservoirs HIV/AIDS, Immunology
Targeting latent HIV-1 Reservoirs with the Antibody-Drug Conjugate, Brentuximab Vedotin HIV/AIDS, Immunology
HIV Cures - Paving the way towards elimination of HIV persistent CD4 T cell in vivo HIV/AIDS, Immunology
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells HIV/AIDS, Drug and Diagnostics Development
Impact of Sirolimus (Rapamycin) on HIV-1 Persistence and Immune Function HIV/AIDS, Drug and Diagnostics Development
Regulatory circuits and virulence in candida albicans Opportunistic Infection
Transcriptional rewiring of aging pathways and dietary restriction effects in yeasts Opportunistic Infection
Reaching Adolescent Girls and Young Women through Girl-friendly Drug Vendors Jenny Liu, PhD, MPP, MA HIV/AIDS, Family Planning, Adolescent Health, Access or Barriers to Care
Reaching 90 90 90 in Adolescents in Zambia: Using all our SKILLZ Jenny Liu, PhD, MPP, MA HIV/AIDS, Women's Health, Adolescent Health
Identifying barriers to diabetes and HIV co-management in vulnerable populations Kartika Palar, PhD HIV/AIDS, Diabetes, Women's Health
Effect of Metformin on Immune Recovery in HIV Patients with Diabetes Michael J. Reid, MD HIV/AIDS, Diabetes
Improving care delivery for people living with HIV, TB and other chronic diseases through diplomacy Michael J. Reid, MD Infectious Disease, Sexually Transmitted Infections (STIs), HIV/AIDS, Opportunistic Infection, Tuberculosis, Policy and Standards of Care, Systematic Reviews and Guideline Development, Health Systems Strengthening
Director of TREAT Asia and VP of Global Initiatives for amfAR Annette Sohn, MD HIV/AIDS, Policy and Standards of Care, Systematic Reviews and Guideline Development, Epidemiology and Surveillance
p24 Antigen and Alternative Markers in Infants, Vietnam Annette Sohn, MD HIV/AIDS, Drug and Diagnostics Development, Newborn and Infant Health
Estimating the Effect of Indoor Residual Spraying on Maternal Morality, Low-Birthweight and Perinatal Mortality Among HIV-Infected Pregnant Women Living in the HAART Era Hugh Sturrock, PhD HIV/AIDS, Malaria, Women's Health, Newborn and Infant Health
Drug Use and HIV/STI Risk Trajectories in Court-Involved, Non-Incarcerated Youth HIV/AIDS, Adolescent Health
Dating Violence Prevention for Juvenile Justice Girls HIV/AIDS, Adolescent Health, Patient and Peer Education
Comprehensive HIV/AIDS Youth Services in San Francisco Colette L. Auerswald, MD, MS HIV/AIDS, Risk Reduction and Prevention
HIV risk and Resilience among transgender female youth Colette L. Auerswald, MD, MS HIV/AIDS, Risk Reduction and Prevention
Vulnerable youth, homelessness, and risk behaviors Colette L. Auerswald, MD, MS HIV/AIDS, Sexually Transmitted Infections (STIs), Access or Barriers to Care, Stigma and Discrimination
Homeless Youth: Street Culture, Social Networks and HIV-Risk Colette L. Auerswald, MD, MS HIV/AIDS, Adolescent Health, Access or Barriers to Care, Stigma and Discrimination
Comprehensive HIV/AIDS Youth Services in San Francisco Colette L. Auerswald, MD, MS HIV/AIDS, Risk Reduction and Prevention
Street START (Street Testing and Rapid Testing) Project Colette L. Auerswald, MD, MS HIV/AIDS, Adolescent Health, Access or Barriers to Care, Stigma and Discrimination, Engagement in Care
Outreach-based STI and HIV testing for street youth in San Francisco Colette L. Auerswald, MD, MS Sexually Transmitted Infections (STIs), HIV/AIDS, Adolescent Health, Stigma and Discrimination, Risk Reduction and Prevention
Developing A Sexual Network Intervention for HIV Prevention Colette L. Auerswald, MD, MS HIV/AIDS, Risk Reduction and Prevention
PrEP disengagement in stimulant and heavy alcohol using men who have sex with men and transgender women. HIV/AIDS, Substance Abuse
Blood safety standards and lab capacity in low & mid income countries Elizabeth Donegan, MD HIV/AIDS, Infectious Disease, Transfusion Medicine, Training International Scholars and Clinicians, Distance learning and mentoring
HIV epidemiology among vulnerable populations in Iran Ali Mirzazadeh, PhD, MD, MPH HIV/AIDS, Women's Health, Access or Barriers to Care, Stigma and Discrimination, Policy and Standards of Care, Epidemiology and Surveillance
Designing and pilot testing methods for a cohort study of people who inject drugs for future HIV and HCV prevention research in Iran Ali Mirzazadeh, PhD, MD, MPH HIV/AIDS, Substance Abuse
HARC Center: HIV Accessory and Regulatory Complexes Alan Frankel, PhD Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Immunology
Improving engagement in care via Community-based mHealth Motivational Interviewing Tool for HIV-positive youth (COMMIT+) Bibhav Acharya, MD HIV/AIDS, Training and Capacity Building, Training International Scholars and Clinicians, Patient and Peer Education
A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia Steven Stoltz, MD Opportunistic Infection, Chronic Respiratory Disease
Population Genetics of the PO1 Locus of SIV and HIV-1 Eric Delwart, PhD HIV/AIDS, Transfusion Medicine, Genetics, Epidemiology and Surveillance
The Transnational Cohort: Global HIV Epidemiology And Prevention Research For Transwomen. Glenn-Milo Santos, PhD, MPH HIV/AIDS, Access or Barriers to Care, Stigma and Discrimination, Risk Reduction and Prevention
Intermittent Naltrexone among Polysubstance-using Men who have Sex with Men (MSM) Glenn-Milo Santos, PhD, MPH HIV/AIDS, Implementation and Behavioral Science, Substance Abuse
The Better THAN Study: Targeting Heavy Alcohol with Naltrexone among MSM Glenn-Milo Santos, PhD, MPH HIV/AIDS, Implementation and Behavioral Science, Substance Abuse
Linkages Between Methamphetamine, Alcohol, and Sexual Risk Behavior Among PWID Glenn-Milo Santos, PhD, MPH HIV/AIDS, Substance Abuse
Pediatric Kaposi Sarcoma, Botswana 2012 HIV Clinical Management Guidelines Anu Agrawal, MD HIV/AIDS, Cancer/Oncology, Pediatrics
Kaposi Sarcoma Subgroup of WHO Guidelines Development Group for HIV-Associated Skin and Oral Conditions Anu Agrawal, MD HIV/AIDS, Cancer/Oncology, Pediatrics
Long distance mentoring in global oncology Anu Agrawal, MD HIV/AIDS, Cancer/Oncology
Global Strategies for HIV Prevention Arthur Ammann, MD HIV/AIDS, Women's Health, Labor and Delivery, Family Planning, Pediatrics, Newborn and Infant Health, Access or Barriers to Care
Structural Determinants of the Patient Experience of HIV Care in Tyler, Texas Emma Botta, MS HIV/AIDS, Engagement in Care, Treatment Adherence
Development and validation for an HPLC-UV multiplex assay for therapeutic drug monitoring of antiretroviral drugs in Uganda Allan Buzibye, Bsc HIV/AIDS, Pharmacology and Drug Treatment
The impact of comprehensive food program on adherence to antiretroviral therapy among people living with HIV in San Francisco: a mixed methods study Loulou Chayama, MS HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Treatment Adherence
The ACA and People Living with HIV/AIDS: A Retrospective Policy Analysis to Inform Integrated HIV Care in the ACA Era Brian Chirairo, MS HIV/AIDS, Health Economics and Effectiveness, Access or Barriers to Care
PreP for HIV Prevention in South Africa and Zambia: A Comparative Policy Analysis Marguerite Hanley, MS HIV/AIDS, Systematic Reviews and Guideline Development
Investigating the Role of Stigma on Fertility Desire among HIV-positive Women in Bangkok, Thailand Kala Mehta, DSc, MPH HIV/AIDS, Family Planning
Transfusion science and HIV, HTLV, and dengue research in Brazil Philip Norris, MD Infectious Disease, HIV/AIDS, Immunology, Health Systems Strengthening, Risk Reduction and Prevention, Training and Capacity Building
Investigating the Impact of In Utero HIV or Malaria Exposure on CD4+ T Cell Development HIV/AIDS, Malaria, Newborn and Infant Health
Identifying the role of opportunistic pathogens including Giardia, Cryptosporidia, Microsporidia and Mycobacterium avium Robert Owen, MD Opportunistic Infection, Zoonosis, Emerging Disease, and Drug Resistance, Occupational and Environmental Disease
A Qualitative Study on the Restructuring of HIV Care in the United States: Perspectives of HIV Positive Patients on Structural Changes in Care Teams at Two HIV Clinics Noor Raad, MS HIV/AIDS, Health Systems Strengthening, Risk Reduction and Prevention
HIV Global Strategic Information Education and Training in Kenya Sandy Schwarcz, MD, MPH HIV/AIDS
Targeted Behavioral Incentives for Improving Tuberculosis (TB) Diagnostic Evaluation Outcomes Priya Shete, MD HIV/AIDS, Tuberculosis
HIV Care in Patients with Concurrent Mental Health or Substance Abuse Diagnoses Fredrik von Beetzen, MD HIV/AIDS
Burkitt’s lymphoma and Kaposi’s sarcoma in Uganda John Ziegler, MD, MSc Infectious Disease, HIV/AIDS
Deputy Director of the International Traineeships in AIDS Prevention Studies (ITAPS) Debbie Brickley, DrPH, MPH HIV/AIDS, Epidemiology and Surveillance, Training International Scholars and Clinicians
Antimalarial drugs in Ugandan populations Melissa Conrad, PhD HIV/AIDS, Malaria, Drug and Diagnostics Development, Pharmacology and Drug Treatment, Pediatrics
Preferences of Patients with HIV for Differentiated Care in Kenya: A Discrete Choice Experiment Sagar Dommaraju, MS HIV/AIDS, Implementation and Behavioral Science
HIV surveillance, data analysis, and data use Michael Grasso, MPH HIV/AIDS, Epidemiology and Surveillance
Engagement in Clinical Care for HIV-Infected Individuals Leaving Jail Kim Koester, PhD HIV/AIDS, Engagement in Care
Mental health and HIV in adolescents in Malawi Susan Kools, RN, PhD HIV/AIDS, Neurology and Mental Health, Adolescent Health
Stigma and Discrimination Against HIV-Positive Young Adults in Bangkok, Thailand Rhea Mathew, MS HIV/AIDS, Stigma and Discrimination
Social determinants and consequences of household food insecurity among persons living with HIV/AIDS Jason Nagata, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Adolescent Health
Systematic reviews of qualitative and quantitative data on global health topics Jason Nagata, MD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Implementation and Behavioral Science
HIV, Agriculture, Food Security, and Nutrition in western Kenya Tammy Nicastro, MS HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity
Assessing climate change awareness and climate-adaptive agricultural strategies in Shamba Maisha, an integrated HIV-care and agricultural livelihood intervention to improve nutrition and health in Western Kenya Tammy Nicastro, MS HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Patient and Peer Education
A peer educator-delivered HIV self-testing intervention for female sex workers in Zambian border towns Catherine Oldenburg, ScD, MPH HIV/AIDS, Access or Barriers to Care, Engagement in Care, Treatment Adherence
The Casual Impact of HIV Self-tests on HIV Testing Among Female Sex Workers in Kampala, Uganda Catherine Oldenburg, ScD, MPH HIV/AIDS, Access or Barriers to Care, Engagement in Care, Treatment Adherence, Patient and Peer Education
Tuberculosis guidelines and best practices internationally Sarah Royce, MD, MPH Zoonosis, Emerging Disease, and Drug Resistance, HIV/AIDS, Tuberculosis
Clinical care and medical education David Sears, MD Infectious Disease, HIV/AIDS, Malaria
Cost-effectiveness Analysis of “Safer” Conception Strategies for HIV-Discordant Couples in Zimbabwe Carolyn Smith Hughes, MS HIV/AIDS, Family Planning
Aligning datasets for in-country decision making Hilary Spindler, MPH HIV/AIDS, Epidemiology and Surveillance, Global Strategic Information
HIV bio-behavioral surveillance studies in Ghana and Mozambique Kelly Taylor, PhD HIV/AIDS, Epidemiology and Surveillance, Implementation and Behavioral Science
Pre-exposure Prophylaxis for People Involved in Criminal Justice Systems Emily Dauria, MD, PhD HIV/AIDS, Adolescent Health, Access or Barriers to Care, Stigma and Discrimination
Integrated Community-based Treatment of HIV and Hypertension in Zambia Monika Roy, MD HIV/AIDS, Implementation and Behavioral Science, Engagement in Care, Treatment Adherence
Improving access to quality healthcare for people living with HIV Mary McQuilkin, BSN, RN, MSN, NP, MPH HIV/AIDS, Access or Barriers to Care, Immigration and Migration
Immigrant Status — a Perceived Barrier to HIV Treatment and Care in San Francisco, California Emma Bohannon, MS HIV/AIDS, Access or Barriers to Care, Immigration and Migration, Stigma and Discrimination
Transportability of Causal Effects to Inform HIV Pre-exposure Prophylaxis Implementation Megha L. Mehrotra, MPH HIV/AIDS, Epidemiology and Surveillance
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya Emily L. Tuthill, PhD HIV/AIDS, Newborn and Infant Health, Treatment Adherence
Understanding the role of food insecurity and depression in non-adherence to Option B+ among perinatal Kenyan women living with HIV: a Syndemics approach Emily L. Tuthill, PhD HIV/AIDS, Malnutrition, Micronutrients, Food Insecurity, Neurology and Mental Health, Women's Health, Newborn and Infant Health, Treatment Adherence
Family Composition and Mental Health: Promoting ART Adherence in the Age of UNAIDS 90-90-90 Target Lynhea Anicete, MS HIV/AIDS, Treatment Adherence
Understanding Patient Preferences for HIV Care and Treatment in San Francisco: Evidence from a Discrete Choice Experiment Madellena Conte, MS HIV/AIDS, Implementation and Behavioral Science, Treatment Adherence
Understanding the Risk of HIV/AIDS in Ugandan Female Sex Workers Nardos Darkera, MS HIV/AIDS, Occupational and Environmental Disease
HIV/Drug Abuse Prevention Research Ethics Training Institute John A. Sauceda, MD HIV/AIDS, Access or Barriers to Care, Engagement in Care, Treatment Adherence
An adaptive treatment intervention for depression and engagement in HIV care among Latinos living with HIV John A. Sauceda, MD HIV/AIDS, Neurology and Mental Health
Expansion of a multicountry QI learning network to accelerate adoptions of interventions to reduce HIV related stigma and discriminations in healthcare settings Bruce D. Agins, MD, MPH HIV/AIDS, Stigma and Discrimination
Technical Assistance for Quality Management Capacity Building in Haiti Bruce D. Agins, MD, MPH HIV/AIDS, Implementation and Behavioral Science
UCSF and IAPAC Fast Track Cities Initiative Bruce D. Agins, MD, MPH HIV/AIDS, Stigma and Discrimination, Engagement in Care, Treatment Adherence
Ending the Epidemic Bruce D. Agins, MD, MPH HIV/AIDS, Engagement in Care, Treatment Adherence
A Formative Assessment of the Continuum of Care Needs of HIV-Positive Men who Have Sex with Men in Ghana Akua Gyamerah, DrPH, MPH HIV/AIDS, Engagement in Care, Treatment Adherence
Engagement and retention in tuberculosis care services among people living with HIV in Lusaka, Zambia: does gender matter?​ Andrew Kerkhoff, MD, PhD HIV/AIDS, Tuberculosis, Stigma and Discrimination, Engagement in Care, Treatment Adherence
Water and toilet access on medication adherence among Zambian women who are HIV positive and enrolled in Option B+ treatment Jerry Nutor, PhD, RN, MS HIV/AIDS, Occupational and Environmental Disease, Women's Health, Family Planning, Pediatrics, Treatment Adherence
Evaluation of an African specific Donor Health Questionnaire for HIV screening in Cameroonian blood services Claude Tayou-Tagny, MCR/MPH/MS, MD, MSC HIV/AIDS, Transfusion Medicine
Leveraging Social Networks to Improve Retention in Care and Viral Suppression Among HIV-infected Youth in East Africa Lillian B. Brown, MD, PhD HIV/AIDS, Adolescent Health, Health Economics and Effectiveness, Engagement in Care
Investigating into the social, health and economic vulnerabilities and resilience of children of women at high risk of HIV in Kampala Agnes Ssali, PhD HIV/AIDS, Women's Health
The Transnational Cohort: global HIV epidemiology and prevention research for transwomen Paul D. Wesson, PhD HIV/AIDS
The Influence of Pregnancy on Pre-Exposure Prophylaxis (PrEP) Adherence Amongst Human Immunodeficiency Virus (HIV) Negative High-Risk Young Women in Kampala, Uganda: A Qualitative Assessment Shivali Joshi, MS HIV/AIDS, Adolescent Health, Risk Reduction and Prevention
Hepatitis C Clearance in HCV, HTLV-I and HIV co-infected Patients in Salvador, Brazil Chloe LeMarchand, MS, MD HIV/AIDS, Infectious Disease, Epidemiology and Surveillance